Multiplexed bioassay device with electronic readout
By designing a biometric device for multi-fluid chambers and light conduits, combined with microprocessor-controlled heating and photoelectric sensors, the problems of expensive instruments and complex analysis in the prior art are solved, and low-cost, accurate biometric and diagnostic capabilities are achieved. .
Patent Information
- Application Number
- CN202111084033.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-09-14
- Filing Date
- 2018-07-27
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing bioassay systems rely on expensive instruments, making it difficult to achieve accurate reaction temperature regulation and optical change measurements in low-cost and external medical scenarios, and sample preparation and result analysis are complex.
A device including a plurality of fluid chambers and a light conduit is designed to form an independent continuous fluid path by coupling the first part and the second part, nucleic acid amplification reaction is performed using a drying reagent and a photoelectric sensor, and controlled by a microprocessor. Heating elements and light emitting elements realize detection and analysis of optical properties.
It realizes accurate measurement of optical changes in reaction volume under low-cost conditions, simplifies sample preparation and result analysis, and is suitable for rapid diagnosis of external medical scenarios.
Smart Images

Figure CN113777011B_ABST
Abstract
Description
[0001] This application is a divisional application of an invention patent application with an international filing date of July 27, 2018, which entered the Chinese national phase on May 7, 2020, Chinese national application number 201880072099.2, and invention name “Multiplexed bioassay device with electronic readout”.
[0002] introduction
[0003] Bioassays are used to determine one or more characteristics of a biological sample. Such assays can qualitatively assess and / or quantitatively measure the presence, amount, and / or functional activity of one or more analytes in a biological sample. Such assessments can be performed based on changes or no changes that occur in the assay. For example, after the biological sample is assayed, the change in transmittance and / or color of the indicator indicates one or more characteristics of the sample being assessed, such as the presence, absence, or amount of an analyte suspected to be present in the sample. Background Art
[0004] Most bioassay systems rely on expensive instruments for analysis. Typically, this analysis involves detecting changes in optical properties (such as absorbance or fluorescence) over time in the reaction volume. These optical property signals are then analyzed and analytes in biological samples that are typically used for health monitoring or disease diagnosis are determined. With the increase in health care costs, people are very interested in developing low-cost diagnostic devices that can be used outside traditional laboratory scenarios (e.g., instant medical clinics, pharmacies, or homes). In addition, many bioassay chemistries that simplify sample preparation workflows (e.g., eliminating purification requirements) and result analysis (e.g., by colorimetric analysis) are available, making them ideal for these scenarios. However, the key challenge remains the design of low-cost instruments that can accurately measure optical changes in the reaction volume while adjusting the reaction temperature. Summary of the invention
[0005] The disclosed subject matter generally relates to devices and systems for performing biological assays using indicators that modify one or more optical properties of the biological sample being assayed. The subject method comprises generating a reaction product by performing a biochemical reaction on a sample introduced into the device, and reacting the reaction product with an indicator capable of generating a detectable change in an optical property of the sample to indicate the presence, absence, or amount of an analyte suspected of being present in the sample.
[0006] In one aspect, the present disclosure provides an assembly for performing a bioassay. In some embodiments, the assembly includes a first part including a first face and a second part including a second face. The first part and the second part are operably connected to form a plurality of independent continuous fluid paths. In certain embodiments, the continuous fluid path includes a common sample receiving inlet, a plurality of fluid channels, and a plurality of fluid chambers. In other embodiments, each of the plurality of fluid chambers may be substantially equidistant from a single sensing region. As used herein, "substantially equidistant" means that the distance of each of the plurality of fluid chambers from the single sensing region differs by no more than + / -25% from the distance of each of the other fluid chambers from the single sensing region in the plurality of fluid chambers. In some aspects, the plurality of fluid channels may extend from the common sample receiving inlet and may be in fluid communication therewith. Each of the plurality of fluid channels may include an end. In a further aspect, each fluid chamber may include a fluid inlet in fluid communication with an end of one of the plurality of fluid channels. Each fluid chamber may also include an outlet vent at the end of the fluid path. In some embodiments, the second part of the assembly may include a transparent material forming a first plurality of light pipes. In other embodiments, each light conduit of the first plurality of light conduits may be capable of transmitting light between one of the plurality of fluid chambers and the single sensing region.
[0007] In another embodiment of the assembly, the assembly may further include a gasket located between the first part and the second part. In such an embodiment, the gasket may be operably coupled to the first part and the second part to form a fluid seal in the continuous fluid path. In another embodiment, the gasket may include a thermoplastic elastomer (TPE) overmold. The gasket may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the gasket may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the gasket, the assembly may have a shelf stability exceeding a threshold of 12 months. In some embodiments, the volume of the gasket may be compressed by 5% to 25% when the first part and the second part of the assembly are operably coupled.
[0008] In some aspects, the bioassay is a diagnostic test. In some embodiments of the assembly, the first part may further include a plurality of coupling handles, and the second part may further include a plurality of coupling latches. In another embodiment, each of the plurality of coupling handles may be configured to operatively couple with one of the plurality of coupling latches.
[0009] In further embodiments of the assembly, the outlet vent of each fluid chamber may be sealed by a self-sealing vent material. The self-sealing vent material may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the self-sealing vent material may be pre-dried to a residual moisture of at most 0.2% w / w. Based on this pre-drying of the self-sealing vent material, the assembly may have a shelf stability exceeding a threshold of 12 months.
[0010] In some embodiments, the assembly further comprises a hydrophobic membrane located between the part and the second part. In certain embodiments, the hydrophobic membrane is operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path. In other embodiments, the hydrophobic membrane may be welded to at least one of the first part and the second part using a plurality of energy directors. In further embodiments, the outlet vent of each fluid chamber is sealed by the hydrophobic membrane. The hydrophobic membrane may comprise polytetrafluoroethylene. The hydrophobic membrane may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the hydrophobic membrane may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the hydrophobic membrane, the assembly may have a shelf stability exceeding a threshold of 12 months.
[0011] In certain embodiments of the assembly, the first part and / or the second part may be injection molded. In some embodiments, the second part comprises a material selected from the group consisting of polymethyl methacrylate, polystyrene, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, cyclic olefin copolymers, and polyamides, and combinations thereof. In some embodiments, the first part and the second part may be pre-dried to a residual moisture between 0 and 0.4% w / w. In alternative embodiments, the first part and the second part may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the first part and the second part, the assembly may have a shelf stability exceeding a threshold of 12 months.
[0012] In some embodiments of the assembly, the volume of at least one of the plurality of fluid chambers may be different from the volume of at least another of the plurality of fluid chambers. In alternative embodiments, the volume of each of the plurality of fluid chambers may be between 1 uL and 1100 uL. In other embodiments, the volume of each of the plurality of fluid chambers is the same. In further embodiments, the volume of each of the plurality of fluid chambers is approximately 30 uL.
[0013] In some aspects of the assembly, at least one of the plurality of fluid chambers comprises a dried reagent. In some aspects, the dried reagent is a lyophilized reagent. The dried or lyophilized reagent may comprise a reagent for performing an assay reaction on the sample. In some embodiments, the assay reagent comprises a nucleic acid amplification enzyme and a DNA primer.
[0014] In some embodiments, the assembly may further include a circuit board operatively coupled to the fluid chamber. In other embodiments, the circuit board may further include a microprocessor. The circuit board may include a plurality of light emitting elements, each light emitting element being capable of illuminating one of the plurality of fluid chambers individually. In some embodiments, the plurality of light emitting elements may include an LED. In an alternative embodiment, the plurality of light emitting elements may include a laser. In some embodiments, the microprocessor is programmed to cause each of the plurality of light emitting elements to emit light in a repeating pattern having a repetition frequency in the range of 0.01 to 100 Hz, wherein only one of the plurality of fluid chambers is illuminated at any time. In other embodiments, each of the plurality of fluid chambers is illuminated individually during each repetition of the pattern.
[0015] In some embodiments of the assembly, the circuit board includes a photosensor optically coupled to the single sensing area. The photosensor may include one of a CMOS chip, a photodiode, a phototransistor, a photocell, and a photomultiplier tube. In some embodiments, the photosensor is configured to detect a color change. In other embodiments, the photosensor is configured to detect an absorbance change. The microprocessor may be programmed to analyze a signal received from the photosensor.
[0016] In some embodiments, the circuit board of the assembly may further include a heating element including a ring shape. In other embodiments, the heating element may be configured to heat the multiple fluid chambers. The microprocessor may be programmed to generate a signal transmitted to the heating element. The circuit board may further include a thermal pad including a ring shape, the thermal pad being configured to transfer heat from the heating element to the multiple fluid chambers. In addition, the circuit board may include a temperature sensor. The microprocessor may be programmed to analyze the signal received from the temperature sensor.
[0017] The circuit board of the assembly may also include an electronic result display mechanism. In some embodiments, the microprocessor may be programmed to generate a signal transmitted to the electronic result display mechanism to simply and clearly indicate the results of the assay reaction performed in one or more of the plurality of fluid chambers.
[0018] In some aspects, each of the first plurality of light pipes includes at least one of one or more reflective surfaces and one or more refractive surfaces configured to direct light between one of the plurality of fluid chambers and the single sensing region. In other embodiments, the second part of the assembly further includes a transparent material forming a second plurality of light pipes and each capable of transmitting light between one of the plurality of light emitting elements and one of the plurality of fluid chambers. In further embodiments, each of the second plurality of light pipes further includes at least one of one or more reflective surfaces and one or more refractive surfaces configured to direct light between one of the plurality of light emitting elements and one of the plurality of fluid chambers.
[0019] In certain embodiments of the disclosed assembly, the plurality of fluid channels extend radially from the common sample receiving inlet. In addition, the plurality of fluid chambers may be radially arranged around the single sensing region. In certain aspects, the first plurality of light pipes are radially arranged around the single sensing region. In other aspects, the single sensing region is located at or near a central region of the second part. In some aspects, the central region is defined relative to the location of the plurality of fluid chambers. In some embodiments of the disclosed assembly, the first face and / or the second face may be radially symmetrical.
[0020] On the other hand, the present disclosure provides a system for performing a bioassay. In some embodiments, the system includes an assembly and a circuit board. The assembly may include a first part including a first face and a second part including a second face. The first part and the second part are operably connected to form a plurality of independent continuous fluid paths. In certain embodiments, the continuous fluid path includes a common sample receiving inlet, a plurality of fluid channels, and a plurality of fluid chambers. In some aspects, the plurality of fluid channels may extend from the common sample receiving inlet and may be in fluid communication with it. In other embodiments, each of the plurality of fluid chambers may be substantially equidistant from a single sensing region. As used herein, "substantially equidistant" means that the distance of each of the plurality of fluid chambers from a single sensing region differs by no more than + / -25% from the distance of each of the other fluid chambers from a single sensing region in the plurality of fluid chambers. Each of the plurality of fluid channels may include an end. In a further aspect, each fluid chamber may include a fluid inlet in fluid communication with the end of one of the plurality of fluid channels. Each fluid chamber may also include an outlet vent at the end of the fluid path. In some embodiments, the second part of the assembly may include a transparent material forming a first plurality of light pipes. In other embodiments, each light conduit of the first plurality of light conduits may be capable of transmitting light between one of the plurality of fluid chambers and the single sensing region.
[0021] In some embodiments, the circuit board of the system is coupled to the fluid chamber of the component and includes a microprocessor, a plurality of light emitting elements, a photoelectric sensor, a heating element, a temperature sensor, and an electronic result display mechanism. In some aspects, each of the plurality of light emitting elements is capable of irradiating one of the plurality of fluid chambers of the component individually. In other aspects, the photoelectric sensor is optically coupled to the single sensing area. The heating element may include an annular shape and may be configured to heat the plurality of fluid chambers of the component. In some embodiments, the microprocessor is programmed to cause each of the plurality of light emitting elements to emit light in a repetitive pattern at a repetition frequency, wherein only one of the plurality of fluid chambers is irradiated at any time. In other embodiments, the microprocessor is also programmed to analyze the signal received from the photoelectric sensor, generate a signal transmitted to the heating element, analyze the signal received from the temperature sensor, and generate a signal transmitted to the electronic result display mechanism. In some embodiments, the signal transmitted to the electronic display mechanism causes the display to simply and clearly indicate the result of the assay reaction performed in one or more of the plurality of fluid chambers.
[0022] In another embodiment of the system, the system may further include a gasket located between the first part and the second part. In such an embodiment, the gasket may be operably coupled to the first part and the second part to form a fluid seal in the continuous fluid path. In another embodiment, the gasket may include a thermoplastic elastomer (TPE) overmold. The gasket may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the gasket may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the gasket, the system may have a shelf stability exceeding a threshold of 12 months. In some embodiments, the volume of the gasket may be compressed by 5% to 25% when the first part and the second part of the system are operably coupled.
[0023] In some aspects, the bioassay is a diagnostic test. In some embodiments of the system, the first part may further include a plurality of coupling handles, and the second part may further include a plurality of coupling latches. In another embodiment, each of the plurality of coupling handles may be configured to operatively couple with one of the plurality of coupling latches.
[0024] In further embodiments of the system, the outlet vent of each fluid chamber may be sealed by a self-sealing vent material. The self-sealing vent material may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the self-sealing vent material may be pre-dried to a residual moisture of at most 0.2% w / w. Based on this pre-drying of the self-sealing vent material, the system may have a shelf stability exceeding a threshold of 12 months.
[0025] In some embodiments, the system further comprises a hydrophobic membrane located between the first part and the second part. In certain embodiments, the hydrophobic membrane is operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path. In other embodiments, the hydrophobic membrane may be welded to at least one of the first part and the second part using a plurality of energy directors. In further embodiments, the outlet vent of each fluid chamber is sealed by the hydrophobic membrane. The hydrophobic membrane may comprise polytetrafluoroethylene. The hydrophobic membrane may be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the hydrophobic membrane may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the hydrophobic membrane, the system may have a shelf stability exceeding a threshold of 12 months.
[0026] In certain embodiments of the system, the first part and / or the second part can be injection molded. In some embodiments, the second part includes a material selected from the group consisting of: polymethyl methacrylate, polystyrene, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, cyclic olefin copolymer, polyamide, and combinations thereof. In some embodiments, the first part and the second part can be pre-dried to a residual moisture between 0 and 0.4% w / w. In alternative embodiments, the first part and the second part can be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the first part and the second part, the system can have a shelf stability exceeding a threshold of 12 months.
[0027] In some embodiments of the system, the volume of at least one of the plurality of fluid chambers may be different from the volume of at least another of the plurality of fluid chambers. In alternative embodiments, the volume of each of the plurality of fluid chambers may be between 1 uL and 1100 uL. In other embodiments, the volume of each of the plurality of fluid chambers is approximately 30 uL.
[0028] In certain aspects of the system, at least one of the plurality of fluid chambers comprises a dried reagent. In some embodiments, the dried reagent is a lyophilized reagent. The dried or lyophilized reagent may comprise a reagent for performing an assay reaction on the sample. In some embodiments, the assay reagent comprises a nucleic acid amplification enzyme and a DNA primer.
[0029] In some embodiments, the plurality of light emitting elements may include LEDs. In alternative embodiments, the plurality of light emitting elements may include lasers. In some embodiments, the microprocessor is programmed to cause each of the plurality of light emitting elements to emit light in a repeating pattern having a repetition frequency in the range of 0.01 to 100 Hz. In other embodiments, each of the plurality of fluid chambers is individually illuminated during each repetition of the pattern.
[0030] In some embodiments of the system, the photosensor may include one of a CMOS chip, a photodiode, a phototransistor, a photocell, and a photomultiplier tube. In some embodiments, the photosensor is configured to detect a color change. In other embodiments, the photosensor is configured to detect an absorbance change.
[0031] In some embodiments, the circuit board may further include a thermally conductive pad including a ring shape, the thermally conductive pad being configured to transfer heat from the heating element to the plurality of fluid chambers.
[0032] In some aspects, each of the first plurality of light pipes includes at least one of one or more reflective surfaces and one or more refractive surfaces configured to direct light between one of the plurality of fluid chambers and the single sensing region. In other embodiments, the second part of the system further includes a transparent material forming a second plurality of light pipes, and each is capable of transmitting light between one of the plurality of light emitting elements and one of the plurality of fluid chambers. In further embodiments, each of the second plurality of light pipes also includes at least one of one or more reflective surfaces and one or more refractive surfaces configured to direct light between one of the plurality of light emitting elements and one of the plurality of fluid chambers.
[0033] In certain embodiments of the disclosed system, the plurality of fluid channels extend radially from the common sample receiving inlet. In addition, the plurality of fluid chambers may be radially arranged around the single sensing area. In certain aspects, the first plurality of light pipes are radially arranged around the single sensing area. In other aspects, the single sensing area is located at or near a central region of the second part. In some aspects, the central region is defined relative to the position of the plurality of fluid chambers. In some embodiments of the disclosed system, the first face and / or the second face may be radially symmetric.
[0034] In yet another aspect, the present disclosure provides a method for determining one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample. In some embodiments, the method includes: providing a biological sample including nucleic acid; combining the biological sample with an optical property modifying reagent solution to produce a sample solution; inserting the sample solution into the sample receiving inlet of the above-mentioned system; transferring at least a portion of the sample solution to the fluid inlet of the plurality of fluid chambers of the above-mentioned system, wherein the fluid chambers include an assay reagent, thereby generating a nucleic acid reaction mixture; heating the reaction mixture with the heating element of the above-mentioned system, the reaction generating amplified nucleic acid and a plurality of protons; reacting the protons with the optical property modifying reagent, wherein the reaction is capable of modifying the optical property of the optical property modifying reagent to allow detection of the modified optical property indicating the presence of a suspected analyte in the biological sample; causing each of the plurality of light emitting elements to emit light in the repetitive pattern at the repetitive frequency using the microprocessor of the above-mentioned system; determining one or more characteristics of the sample based on the modified optical property using the photosensor of the above-mentioned system; and using the electronic result display mechanism of the above-mentioned system to simply and clearly indicate the results of the reaction performed in one or more of the plurality of fluid chambers. In some embodiments, transferring at least a portion of the sample solution to the fluid inlets of the plurality of fluid chambers further comprises transferring at least a portion of the sample solution from the common sample receiving inlet to the plurality of extended fluid channels, and from the ends of the plurality of fluid channels to the fluid inlets of the plurality of fluid chambers. In other embodiments, heating the reaction mixture promotes a nucleic acid amplification reaction using the nucleic acid present in the biological sample and the assay reagent, thereby generating amplified nucleic acid and a plurality of protons.
[0035] In some embodiments of the method, each light emitting element individually illuminates one of the plurality of fluid chambers. Furthermore, during each repetition of the repeating pattern, each of the plurality of fluid chambers may be individually illuminated. In other aspects, causing each of the plurality of light emitting elements to emit light in the repeating pattern further comprises causing each of the plurality of light emitting elements to emit light at different and distinct times such that only one of the plurality of fluid chambers is illuminated at any time. In some embodiments, the repetition frequency is in the range of 0.01 to 100 Hz.
[0036] In certain embodiments of the method, the light emitted by each of the plurality of light emitting elements is transmitted to the plurality of fluid chambers through the second plurality of light conduits of the system described above. In a further aspect, the light emitted by each of the plurality of light emitting elements is transmitted to the plurality of fluid chambers through the second plurality of light conduits using at least one of one or more reflective surfaces and one or more refractive surfaces located within the second plurality of light conduits. Additionally, the light emitted by each of the plurality of light emitting elements may be transmitted to the photoelectric sensor through the first plurality of light conduits of the second part of the system described above. Additionally, the light emitted by each of the plurality of light emitting elements may be transmitted to the photoelectric sensor through the first plurality of light conduits using at least one of one or more reflective surfaces and one or more refractive surfaces located within the first plurality of light conduits.
[0037] In some aspects, heating the reaction mixture with the heating element further comprises: transmitting a signal generated by the microprocessor to the heating element. In addition, determining one or more characteristics of the sample using the photoelectric sensor may further comprise: analyzing, by the microprocessor, a signal received from the photoelectric sensor. In addition, the method may further comprise: receiving a signal from the temperature sensor of the above-mentioned system, and analyzing, using the microprocessor, the signal received from the temperature sensor. In another aspect of the method, displaying the determined characteristics using the electronic result display mechanism further comprises: transmitting a signal generated by the microprocessor to the electronic result display mechanism to simply and clearly indicate the results of the reaction performed in one or more of the plurality of fluid chambers.
[0038] In some embodiments, using the photoelectric sensor to determine one or more characteristics of the sample further comprises: using the photoelectric sensor to detect a color change of the sample. In other embodiments, using the photoelectric sensor to determine one or more characteristics of the sample further comprises: using the photoelectric sensor to detect a change in absorbance of the sample.
[0039] In some embodiments, the method further comprises: pre-drying the self-sealing vent material, the first part and the second part, the hydrophobic membrane and / or the gasket of the above system to a residual moisture between 0 and 0.4% w / w. Alternatively, the method may further comprise: pre-drying the self-sealing vent material, the first part and the second part, the hydrophobic membrane and / or the gasket of the above system to a residual moisture of at most 0.2% w / w.
[0040] In some embodiments of the method, the optical property modification reagent solution includes a liquid buffer. In addition, the assay reagent may include a nucleic acid amplification enzyme and a DNA primer. In other embodiments of the method, the assay reagent is dried and may include a lyophilized reagent. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] The present application will be further understood when read in conjunction with the accompanying drawings. For the purpose of illustrating the subject matter, exemplary embodiments of the subject matter are shown in the accompanying drawings; however, the presently disclosed subject matter is not limited to the specific methods, devices, and systems disclosed. In addition, the drawings are not necessarily drawn to scale. In the drawings:
[0042] Figure 1 is a diagram of an apparatus for performing a bioassay according to an embodiment.
[0043] Figure 2A is an illustration of a radially symmetric circular second face of a second piece of a first light pipe having radially arranged fluid chambers according to an embodiment.
[0044] Figure 2B is an illustration of a radially symmetric polygonal second face of a second piece having radially arranged fluid chambers and a first light pipe according to an embodiment.
[0045] Figure 2C is an illustration of a radially symmetric semicircular second face of a second piece of a first light pipe having radially arranged fluid chambers, according to an embodiment.
[0046] Figure 2D is an illustration of a non-radially symmetric circular second face of a second piece of a first light pipe having radially arranged fluid chambers, according to an embodiment.
[0047] Figure 2E is an illustration of a non-radially symmetric circular second face of a second piece of a first light pipe having radially arranged fluid chambers, according to an embodiment.
[0048] Figure 2F is an illustration of a radially symmetric square second face of a second piece of a first light pipe having radially arranged fluid chambers and according to an embodiment.
[0049] Figure 3A is an illustration of a bird's eye view of uncoupled components of a device for performing a bioassay, according to an embodiment.
[0050] Figure 3B is an illustration of a bottom view of uncoupled components of a device for performing a bioassay according to an embodiment.
[0051] Figure 3C is an illustration of a bird's eye view of alternative uncoupled components of a device for performing a bioassay, according to an embodiment.
[0052] Figure 3D is an illustration of a bottom view of alternative uncoupled components of a device for performing a bioassay according to an embodiment.
[0053] Figure 3E is an illustration of a cross-section of an apparatus for performing a biological assay according to an embodiment.
[0054] Figure 4 is an illustration of a cross-section of a second part of an apparatus for performing a biological assay according to an embodiment.
[0055] Figure 5 is an illustration of a cross-section of an apparatus for performing a biological assay according to an embodiment.
[0056] Figure 6 is an image of a ray tracing simulation of light rays generated by an apparatus for performing a biological assay according to an embodiment.
[0057] Figure 7 is an image of a ray tracing simulation result according to an embodiment, which shows the Figure 6 Optical intensity at the sensing area of a ray tracing simulation.
[0058] Figure 8 is an illustration of a system for performing a bioassay, according to an embodiment.
[0059] Fig. 9 is a block diagram depicting the interactions between powered components of a system for performing biometric assays, according to an embodiment.
[0060] Fig. 10A is a thermal image of a heating element of a system for performing a biological assay according to an embodiment.
[0061] Fig. 10B is a bar graph depicting average temperature measurements of each of a plurality of fluid chambers of a system for performing a biological assay when heated by a heating element, according to an embodiment.
[0062] Fig.11is a flow chart of a method of performing a biometric assay using a system for performing a biometric assay according to an embodiment.
[0063] Fig.12 is a line graph depicting absorbance signals detected by a photosensor of a system for performing a biological assay over time for a plurality of reaction mixtures contained within a plurality of fluid chambers of the system, according to an embodiment. DETAILED DESCRIPTION
[0064] Devices, systems and methods are provided for performing biological assays using indicators that modify one or more optical properties or aspects thereof of a biological sample being assayed. The subject methods include generating a reaction product by performing a biochemical reaction on a sample introduced into the device, and reacting the reaction product with an indicator capable of generating a detectable change in an optical property of the sample to indicate the presence, absence or amount of an analyte suspected of being present in the sample.
[0065] Before describing the present invention in more detail, it should be understood that the present invention is not limited to the specific embodiments described, as such embodiments may of course vary. It should also be understood that the terminology used herein is only for the purpose of describing specific embodiments, and is not intended to be restrictive, as the scope of the present invention will be limited only by the appended claims.
[0066] If a range of values is provided, it is understood that each intervening value between the upper and lower limits of the range (up to one-tenth of the unit of the lower limit, unless the context clearly states otherwise) and any other stated or intervening values within the stated range are encompassed within the present invention. The upper and lower limits of these smaller ranges may be independently included within these smaller ranges and are also encompassed within the present invention, subject to any specifically excluded limits within the stated ranges. If the stated range includes one or both of the stated limits, ranges excluding one or both of these included limits are also encompassed within the present invention.
[0067] Certain ranges provided herein may be preceded by the term "about". The term "about" is used herein to indicate exactly the exact number that follows it, as well as numbers that are close to or approximately the number that follows the term. In determining whether a number is close to or approximately a specifically recited number, the close or approximate unrecited number may be a number that, in the context in which it appears, provides a substantial equivalence to the specifically recited number.
[0068] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, representative exemplary methods and materials are now described.
[0069] All publications and patents cited in this specification are incorporated herein by reference, as if each individual publication or patent was specifically and individually indicated as being incorporated by reference, and are incorporated herein by reference to disclose and describe the methods and / or materials involved when citing the publication. Reference to any publication is directed to its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate the publication due to prior invention. In addition, the publication date provided may be different from the actual publication date, which may need to be independently confirmed.
[0070] It should be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. It should be further noted that the claims may be drafted to exclude any optional elements. Thus, this statement is intended to serve as antecedent basis for use of exclusive terminology such as "solely," "only," and the like in connection with the recitation of claim elements, or use of a "negative" limitation.
[0071] In addition, certain embodiments of the disclosed devices and / or associated methods may be represented by drawings that may be included in the present application. Embodiments of the device and their specific spatial characteristics and / or capabilities include those embodiments of the device shown or generally shown in the drawings or that can be reasonably inferred from the drawings and their specific spatial characteristics and / or capabilities. Such characteristics include, for example, one or more (e.g., one, two, three, four, five, six, seven, eight, nine, or ten, etc.) of the following items: symmetry around a plane (e.g., a cross-sectional plane) or an axis (e.g., an axis of symmetry), an edge, a perimeter, a surface, a specific orientation (e.g., proximal; distal) and / or a number (e.g., three surfaces; four surfaces), or any combination thereof. Such spatial characteristics also include, for example, the lack (e.g., specific lack) of one or more (e.g., one, two, three, four, five, six, seven, eight, nine or ten, etc.) of the following: symmetry about a plane (e.g., a cross-sectional plane) or axis (e.g., an axis of symmetry), an edge, a perimeter, a surface, a particular orientation (e.g., proximal) and / or a number (e.g., three surfaces), or any combination thereof.
[0072] It will be apparent to those skilled in the art after reading this disclosure that the individual embodiments described and illustrated herein each have discrete components and features that can be easily separated or combined with the features of any of the other several embodiments without departing from the scope or spirit of the invention. Any described method can be performed in the order of events described or in any other order that is logically possible.
[0073] In further describing the subject invention, the subject apparatus for practicing the subject apparatus will be discussed in greater detail and then associated methods will be reviewed.
[0074] definition
[0075] Unless otherwise defined, terms used in the claims and specification are defined as set out below.
[0076] The term "colorimetry" or "colorimetry" refers to a technique for quantifying or otherwise observing the concentration of a colored compound in a solution. "Colorimetric detection" refers to any method for detecting such colored compounds and / or color changes of compounds in solution. Methods may include visual observation, absorbance measurement, or fluorescence measurement, among others.
[0077] The term "halochromic agent" refers to a composition that changes color when certain chemical reactions occur. In particular, a halochromic agent may refer to a composition that changes color as pH changes. Different halochromic agents may change color within different pH transition ranges.
[0078] The term "transition pH range" or "pH transition range" refers to the pH range over which the color of a particular sample or compound changes. The specific transition pH range of a sample may depend on the halochromic agent in the sample (see above).
[0079] The term "nucleic acid amplification" or "amplification reaction" refers to a method of amplifying DNA, RNA, or modified versions thereof. Nucleic acid amplification includes several techniques, such as isothermal reactions or thermal cycling reactions. More specifically, nucleic acid amplification includes methods such as polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), strand displacement amplification (SDA), recombinase polymerase amplification (RPA), helicase-dependent amplification (HDA), multiple displacement amplification (MDA), rolling circle amplification (RCA), and nucleic acid sequence-based amplification (NASBA). The term "isothermal amplification" refers to an amplification method performed without changing the temperature of the amplification reaction. Protons are released during the amplification reaction: For each deoxynucleotide triphosphate (dNTP) added to the single-stranded DNA template during the amplification reaction, one proton (H + ).
[0080] The term "sufficient amount" means an amount sufficient to produce a desired effect, for example, an amount sufficient to modulate protein aggregation in a cell.
[0081] Device
[0082] Various aspects of the subject disclosure include devices for performing biological assays by modifying the optical properties of a biological sample and detecting these modified properties. As used herein, a "biological sample" is a sample containing an amount of organic material (e.g., one or more organic molecules, such as one or more nucleic acids, e.g., DNA and / or RNA, or portions thereof) that can be obtained from a subject. Thus, a "biological sample assay" is a test performed on a biological sample to evaluate one or more properties of the sample. In some aspects, the biological sample is a nucleic acid amplification sample, which is a sample that includes or is suspected of including one or more nucleic acids, or portions thereof, that can be amplified according to embodiments of the subject.
[0083] The biological sample may be provided by a subject and include one or more cells, such as tissue cells of the subject. As used herein, the term "tissue" refers to one or more cell aggregates or multiple different types of such aggregates having similar functions and structures in a subject (e.g., a living organism, such as a mammal, such as a human). Tissue may include, for example, organ tissue, muscle tissue (e.g., cardiac muscle; smooth muscle; and / or skeletal muscle), connective tissue, neural tissue, and / or epithelial tissue. In some versions, the tissue may include cells from the inside of a subject's cheek and / or cells in the subject's saliva.
[0084] As noted above, biological samples can be provided by subjects. In certain embodiments, subjects are "mammalian" or "mammal" subjects, wherein these terms are widely used to describe organisms in the class Mammalia, including Carnivora (e.g., dogs and cats), Rodentia (e.g., mice, guinea pigs and rats) and Primates (e.g., humans, chimpanzees and monkeys). In some embodiments, subjects are humans. The term "human" may include two sexes and human subjects at any stage of development (i.e., fetus, newborn, infant, teenager, teenager, adult), wherein in certain embodiments, human subjects are teenagers, teenagers or adults. Although the device and method described herein can be applied to human subjects, it should be understood that the subject device and method can also be applied to other subjects, that is, applied to "non-human subjects".
[0085] As indicated herein, in some versions, the biological sample can be a prepared biological sample. The prepared biological assay sample is, for example, a biological assay sample that has been treated by exposing the sample to a preparation solution, such as a solution including a lysing agent, such as a detergent. Therefore, in some embodiments, the biological sample is a lysate. Such preparation enables the prepared biological sample to react with, for example, an assay reagent and / or an optical property modifying reagent when exposed to it. The exposure may include lysing the cells of the sample with a lysing agent of the preparation solution and / or extracting nucleic acids therefrom. Such extracted nucleic acids can be released into the resulting prepared sample solution. In some embodiments, a step of extracting genomic deoxyribonucleic acid (DNA) from the biological sample is included. When necessary, the preparation solution is a nucleic acid amplification preparation solution, and the nucleic acids of the sample prepared in the solution are exposed to amplification, such as isothermal amplification.
[0086] Additionally, as used herein, the phrase "optical property" refers to one or more optically discernible characteristics, such as characteristics derived from the wavelength and / or frequency of radiation (e.g., light) emitted by or transmitted through a sample before, during, or after an assay reaction performed using the sample, such as color, absorbance, reflectivity, scattering, fluorescence, phosphorescence, etc. Thus, modifying an optical property refers to changing such properties.
[0087] Figure 1 1 is an illustration 100 of a device 105 for performing a bioassay according to an embodiment. In various embodiments, the device 105 includes a first part 110 and a second part 115. In some embodiments, at least one of the first part 110 and the second part 115 is injection molded. In alternative embodiments, one of the first part 110 and the second part 115 may not be injection molded. For example, one of the first part 110 and the second part 115 may include a film.
[0088] In various embodiments, the device 105 including the first part 110 and the second part 115 includes one or more materials, including, for example, polymeric materials (e.g., materials having one or more polymers including, for example, plastic and / or rubber) and / or metallic materials. Materials that may constitute any of the devices 105 include, but are not limited to: polymeric materials, for example, elastomeric rubbers, such as natural rubber, silicone rubber, ethylene-vinyl rubber, nitrile rubber, butyl rubber; plastics, such as polytetrafluoroethylene or polytetrafluoroethylene (PFTE), including expanded polytetrafluoroethylene (e-PFTE), polyethylene, polyester (DacronTM), nylon, polypropylene, polyethylene, high-density polyethylene (HDPE), polyurethane, polydimethylsiloxane (PDMS); or adhesives, such as acrylic adhesives, silicone adhesives, epoxy resin adhesives, or any combination thereof, etc.; metals and metal alloys, for example, titanium, chrome, aluminum, stainless steel, etc.; etc. In various embodiments, the material is a transparent material, and therefore, allows light within the visible spectrum to pass therethrough effectively.
[0089] In some embodiments, the first part 110 and the second part 115 can be pre-dried to a residual moisture between 0 and 0.4% w / w. In a preferred embodiment, the first part 110 and the second part 115 can be pre-dried to a residual moisture of at most 0.2% w / w. Based on this pre-drying of the first part 110 and the second part 115, the device 105 can have a shelf stability exceeding a threshold of 12 months.
[0090] The first part 110 includes a first face and the second part 115 includes a second face. The faces of the first part 110 and the second part 115 may include any shape. In addition, the faces of the first part 110 and the second part 115 may be radially symmetrical or non-radially symmetrical. However, in a preferred embodiment, the first face and the second face are radially symmetrical and / or substantially radially symmetrical. For example, the faces of the first part 110 and the second part 115 may include a circle, a hexagon, and / or another multi-sided polygon. Multiple embodiments of the radially symmetrical face and the non-radially symmetrical face of the second part 115 are described in detail. FIG. 2A to FIG. 2F As shown in and referenced below FIG. 2A to FIG. 2F The following references FIG. 2A to FIG. 2F and Figure 4 The advantages of at least substantial radial symmetry of the first part 110 and the second part 115 are discussed in more detail.
[0091] As noted above and as Figure 1As shown, the first part 110 can be coupled to the second part 115 to form a single device 105. In some embodiments, the first part 110 is operatively coupled to the second part 115. As used herein, "operatively coupled", "operatively connected" and "operatively attached" mean connected in a particular manner so as to allow the disclosed device to operate in the manner described herein and / or the method to be effectively performed in the manner described herein. For example, operatively coupled may include removably coupling or fixedly coupling two or more aspects. Operationally coupled may also include fluidically and / or electrically and / or matably and / or adhesively coupling two or more components. In addition, as used herein, "removably coupled" means coupling in a manner in which two or more coupled components can be repeatedly uncoupled and then recoupled, for example, physically and / or fluidically and / or electrically coupled. For example, in some embodiments, the first part 110 is operatively coupled to the second part 115 to form a plurality of independent continuous fluid paths.
[0092] In some embodiments, the first part 110 and the second part 115 are coupled using a plurality of coupling handles 120 and a plurality of coupling latches 125. Figure 1 As shown, a plurality of coupling handles 120 are attached to the first part 110, and a plurality of coupling latches 125 are attached to the second part 115. The plurality of coupling handles 120 are configured to be operatively coupled with the plurality of coupling latches 125. Figure 3A and Figure 3B Additional methods for coupling the first part 110 and the second part 115 are discussed in greater detail.
[0093] As noted above, in some embodiments, the first part 110 and the second part 115 are operably connected to form a plurality of independent continuous fluid paths. The plurality of independent continuous fluid paths include a common sample receiving inlet 130, a plurality of fluid channels ( Figure 3B 2 ). Specifically, each fluid path includes a common sample receiving inlet 130, one of the multiple fluid channels, and one of the multiple fluid chambers. As discussed above, this formation of multiple independent continuous fluid paths is advantageous because it enables multiple assays to occur in parallel.
[0094] In some embodiments, the common sample receiving inlet 130 is located at the center of the first part 110 and the second part 115 that are operatively connected. In some aspects, the central area is defined relative to the location of multiple fluid chambers. In alternative embodiments, the common sample receiving inlet 130 may not be eccentric relative to the first part 110 and the second part 115 that are operatively connected. The common sample receiving inlet 130 is configured to receive a sample solution. In some embodiments, the sample solution includes a biological sample. This biological sample may include nucleic acids. In some embodiments, the sample solution also includes additional reagents. For example, the sample solution may include an optical property modifying reagent solution. This optical property modifying reagent solution may also include an optical property modifying reagent and a liquid buffer. According to some embodiments, when a biological sample or one or more aspects thereof is exposed to an optical property modifying reagent, the optical property of the optical property modifying reagent changes due to the presence or absence of a specific marker in the biological sample. Examples of changeable optical properties include color and absorbance. Changes in optical properties can be detected and used to identify the properties of the biological sample. Reference Figure 4 , Figure 5 and Fig.11 Optical property modifying agents and detection of changes in their optical properties are discussed in more detail.
[0095] A plurality of fluid channels extend from and are in fluid communication with the common sample receiving inlet 130, such that fluid can travel from the common sample receiving inlet 130 into the plurality of fluid channels. For example, in embodiments such as those discussed above, a biological sample can travel from the common sample receiving inlet 130 into the plurality of fluid channels. In some embodiments, the fluid channels extend radially from the common sample receiving inlet 130.
[0096] Each of the fluid channels may be shaped as a cylinder or a quadrilateral prism, and may have a length of 10 m or less, such as 1 m or less, such as 10 cm or less, such as 1 mm or less, and / or a diameter, width and / or height of 100 mm or less, such as 10 mm or less, such as 1 mm or less, such as 0.1 mm or less, such as 10 μm or less. Each of the fluid channels may also have a volume of 1100 μL or less, such as 10 μL or less, such as 1 μL or less, such as 0.1 μL or less, such as 1 nL or less. In a preferred embodiment, the size of each of the plurality of fluid channels is the same.
[0097] The fluid channels extend from the common sample receiving inlet 130 to the plurality of fluid chambers. Specifically, each fluid channel extends from the common sample receiving inlet 130 to one of the plurality of fluid chambers. In addition, each fluid channel has a Figure 3B ) ends, and each fluid chamber includes a fluid inlet ( Figure 3BAs shown in FIG. 1 , each fluid channel has an end that is in fluid communication with a fluid inlet of a fluid chamber to which the fluid channel extends. In other words, the fluid can flow from the end of the fluid channel into the fluid inlet of the fluid chamber. After the fluid passes through the fluid inlet, the fluid is located in the fluid chamber.
[0098] In some embodiments, each fluid chamber in the plurality of fluid chambers is associated with a single sensing region ( Figure 4 In other embodiments, each fluid chamber in the plurality of fluid chambers is substantially equidistant from the common sample receiving inlet 130. As used herein, "substantially equidistant" means that the distance between each fluid chamber in the plurality of fluid chambers and a single sensing region differs by no more than + / -25% from the distance between each other fluid chamber in the plurality of fluid chambers and a single sensing region. In further embodiments, the size of each fluid channel in the plurality of fluid channels comprises the same size. In such embodiments, the distance that the fluid travels from the common sample receiving inlet 130 to each fluid chamber is approximately equal, and the time that the fluid travels from the common sample receiving inlet 130 to each fluid chamber is also approximately equal. By being approximately equal, it is expected that the difference of less than or equal to about ±10%, or less than or equal to ±5%, or less than or equal to ±1% and the intermediate range within these limits. Such substantially equidistant between the fluid chamber and the single sensing region, as well as the substantially equidistant between the fluid chamber and the common sample receiving inlet, and the similar size of the fluid channels, further improve the ability of the device 105 to perform multiple determinations in parallel under similar conditions. These and similar conditions produce more controlled and reliable assay results.
[0099] Due to the length of the fluid channel, the fluid channel substantially prevents the movement (e.g., diffusion) of liquid or its components from one fluid chamber to another fluid chamber. Therefore, the fluid chambers are isolated from each other, and the amount of such movement over the duration of the assay is negligible in affecting the assay results.
[0100] Each fluid chamber may be shaped as a cylinder, a rectangular box, a cube, or any combination thereof. Each fluid chamber may also be a microfluidic chamber. For example, in certain embodiments, each fluid chamber may have a volume between 1 μL and 1100 μL. In another embodiment, each fluid chamber may have a volume of approximately 30 μL. In an alternative embodiment, the volume of at least one of the plurality of fluid chambers is different from the volume of at least another of the plurality of fluid chambers.
[0101] In some embodiments, each fluid chamber includes a dried reagent, which may be a lyophilized reagent. In some embodiments, the dried or lyophilized reagent includes an assay reagent. In other embodiments, the assay reagent includes a nucleic acid amplification enzyme and a DNA primer. In such embodiments, the assay reagent achieves amplification of a selected nucleic acid present or suspected of being present in a biological sample. The assay reagent may be dried (e.g., lyophilized) to extend shelf stability of the assay reagent and, therefore, the device 105. Reference FIG. 3A to FIG. 3E and Fig.11 Dried or lyophilized assay reagents located within the fluid chamber are discussed in greater detail.
[0102] In addition to including dried or lyophilized assay reagents, each fluid chamber also includes an outlet vent 135. The outlet vent 135 of each fluid chamber specifies the end of the above-mentioned independent continuous fluid path. In some embodiments, the outlet vent 145 can be sealed with a vent material (not shown).
[0103] The vent material of the sealed outlet vent 145 can be porous, thus having a plurality of holes extending therethrough. The vent material can also have a passively adjustable porosity. As used herein, the phrase "passively adjustable porosity" refers to the ability to have a first configuration and a second configuration, in which one or more gases (e.g., air) can pass therethrough, for example, through a hole, and in which one or more gases and liquids (such as, liquids including biological samples) are prevented from passing therethrough, for example, through a hole, and automatically advance from the first configuration to the second configuration when in contact with the liquid. In the second configuration, the vent material prevents the liquid from evaporating therefrom, for example, through the hole. Moreover, in the second configuration, the vent material can fluidly seal the fluid chamber by covering the outlet vent 135 of the fluid chamber and preventing the fluid from passing therethrough (including evaporation). The vent material can be configured to passively (e.g., automatically without user interaction) advance to the second configuration from the first configuration when one or more liquids (such as, liquids including biological samples) contact the vent material or a portion thereof (e.g., a surface, such as a surface forming a wall of the fluid chamber). Thus, in some versions, the vent material may self-seal with liquids and gases when in contact with liquids.
[0104] Moreover, one or more portions or materials of the vent material may have a passively adjustable porosity. For example, in some versions, the vent material may be comprised of a hydrogel having a passively adjustable porosity. Such a hydrogel may be capable of swelling and reducing the porosity of the porous polymer matrix when in contact with a liquid (e.g., an aqueous liquid).
[0105] In an alternative embodiment, the vent material may include a hydrophobic vent material. For example, the vent material may include polytetrafluoroethylene. FIG. 3C to FIG. 3E Such embodiments are discussed in more detail.
[0106] In other embodiments, the vent material may be composed of a variety of materials, including one or more polymer matrices, such as a porous polymer matrix, such as polyethylene. The vent material may also be composed of a hydrogel, such as carboxymethyl cellulose. Other materials that may also constitute the vent material or a portion thereof, such as a coating, include carbohydrates, proteins, deliquescent materials, nylon, ABS, polycarbonate, and poly(methyl methacrylate) and other hygroscopic materials, or any combination thereof. The vent material may also be or include one or more coatings.
[0107] In certain embodiments, the vent material (such as a self-sealing vent material) can be pre-dried to residual moisture prior to placement onto the outlet vent 145. For example, in some embodiments, the vent material can be pre-dried to a residual moisture between 0 and 0.4% w / w. In a preferred embodiment, the vent material can be pre-dried to a residual moisture of up to 0.2% w / w. By pre-drying the vent material, the shelf life of the vent material, and therefore the shelf stability of the device 105, can be extended. Specifically, by pre-drying the vent material, the device 105 can achieve a shelf stability exceeding a threshold of 12 months.
[0108] exist Figure 1 The final feature of the device 105 visible in FIG. 1 is a plurality of second light guides 140. The plurality of second light guides 140 are used to detect optical properties of the biological sample. Figure 4 and Figure 5 The plurality of second light pipes 140 are discussed in greater detail.
[0109] FIG. 2A to FIG. 2F 1 is a diagram of various embodiments of the second side of the second part 115. Figure 1As discussed, the second face of the second part 115 may be radially symmetric and / or non-radially symmetric. In a preferred embodiment, the second face of the second part 115 is radially symmetric. The radial symmetry of the second part 115 (as well as the first part 110 and the entire device 105) is a preferred method of designing the device 105 so that each of the plurality of fluid chambers 205 is substantially equidistant from the sensing region 215, and more specifically, so that the optical path length between each fluid chamber 205 and a single sensing region 215 is substantially equal, because this substantially equidistant allows for more controlled and reliable determinations. However, in alternative embodiments, the device 105 may not be radially symmetric, but may still maintain substantially equidistant between each fluid chamber 205 and the sensing region 215. As used herein, "substantially equidistant" means that the distance of each of the plurality of fluid chambers from the single sensing region differs by no more than + / - 25% from the distance of each other of the plurality of fluid chambers from the single sensing region. In still further embodiments, the device 105 may be characterized by non-equivalent distances between one or more of the plurality of fluid chambers 205 and the sensing region 215 .
[0110] In addition, although the fact is FIG. 2A to FIG. 2F The fluid chamber 205 and the first light pipe 210 are depicted as being radially arranged around the single sensing region 215 , but in alternative embodiments, the fluid chamber 205 and the first light pipe 210 may be non-radially arranged around the single sensing region 215 . FIG. 2A to FIG. 2F Alternative arrangements of the second face of the second part 115 disclosed in are also possible.
[0111] Figure 2A 200A is an illustration of a radially symmetric circular second face of a second part 115 having a radially arranged fluid chamber 205 and a first light pipe 210 according to an embodiment. Specifically, the fluid chamber 205 and the first light pipe 210 are radially arranged around a single sensing area 215. In addition, the fluid chamber 205 and the first light pipe 210 are radially symmetric. Note that the first light pipe 210 (hereinafter referred to as Figures 4 to 6 Discussed in more detail, is the path that light travels through between the fluid chamber 205 and a single sensing region 215. Thus, the radial symmetry of the fluid chambers 205 and the first light pipe 210 ensures that the optical path lengths between each of the fluid chambers 205 and the sensing region 215 are equal.
[0112] Figure 2B200B is an illustration of a radially symmetric polygonal second face of a second part 115 having a radially arranged fluid chamber 205 and a first light pipe 210 according to an embodiment. Specifically, the second polygonal face is an octagon. The fluid chamber 205 and the first light pipe 210 are radially arranged around a single sensing area 215. In addition, the fluid chamber 205 and the first light pipe 210 are radially symmetric.
[0113] Figure 2C 200C is an illustration of a non-radially symmetric semicircular second face of a second part 115 with a radially arranged fluid chamber 205 and a first light pipe 210 according to an embodiment. Specifically, the semicircular second face is a deformed semicircle. The fluid chamber 205 and the first light pipe 210 are radially arranged around a single sensing area 215. However, because the semicircular second face itself is non-radial, the fluid chamber 205 and the first light pipe 210 cannot be radially symmetric around the second face.
[0114] Figure 2D 200D is an illustration of a non-radially symmetric circular second face of a second part 115 having radially arranged fluid chambers 205 and first light pipes 210 according to an embodiment. Specifically, the fluid chambers 205 and the first light pipe 210 are radially arranged around a single sensing region 205. In addition, each of the fluid chambers 205 is substantially equidistant from the single sensing region 215. As used herein, "substantially equidistant" means that the distance of each fluid chamber in the plurality of fluid chambers from the single sensing region does not differ by more than + / - 25% from the distance of each other fluid chamber in the plurality of fluid chambers from the single sensing region. However, the circular second face is non-radially symmetric because the fluid chambers 205 and the second light pipe 210 do not occur at uniform intervals along the radius of the circle.
[0115] Figure 2E 200E is an illustration of a non-radially symmetric circular second face of a second part 115 having radially arranged fluid chambers 205 and first light pipes 210, according to an embodiment. Specifically, the fluid chambers 205 and the first light pipes 210 are radially arranged around a single sensing region 205. However, the fluid chambers 205 are not substantially equidistant from the single sensing region 215. Furthermore, the circular second face is non-radially symmetric because the fluid chambers 205 are not of the same size. Therefore, the optical path lengths of the fluid chambers 205 are not equal.
[0116] Figure 2F is an illustration 200F of a radially symmetric square second face with radially arranged fluid chambers 205 and second piece 115 of first light pipe according to an embodiment. The fluid chambers 205 and first light pipe 210 are radially arranged around a single sensing region 215. Additionally, the fluid chambers 205 and first light pipe 210 are radially symmetric.
[0117] Figure 3A is an illustration of a bird's eye view 300A of uncoupled components of a device 105 for performing a bioassay, according to an embodiment. The uncoupled components of the device 105 include a first part 110 and a second part 115.
[0118] As mentioned above Figure 1 As discussed, the first part 110 and the second part 115 are operably coupled to each other to form a plurality of independent continuous fluid paths. In certain embodiments, the first part 110 and the second part 115 are operably coupled without any components being placed between the first part 110 and the second part 115. However, in embodiments such as Figure 3A In an alternative embodiment to the embodiment depicted in , in order to operatively couple the first part 110 and the second part 115, a gasket 320 may be placed between the first part 110 and the second part 115. The gasket 320 may facilitate the formation of multiple independent continuous fluid paths. In an embodiment where the gasket 320 is placed between the first part 110 and the second part 115 and the first part 110 and the second part 115 are operatively coupled, the volume of the gasket may be compressed by 5% to 25%. In certain embodiments, the gasket 320 comprises a thermoplastic elastomer (TPE) overmold. In such embodiments, the gasket 320 may be overmold on the first part 110 and / or the second part 115 to facilitate the sealing of the continuous fluid paths. In some embodiments, the gasket 320 may be pre-dried to a residual moisture between 0 and 0.4% w / w. In a preferred embodiment, the gasket 320 may be pre-dried to a residual moisture of up to 0.2% w / w. Based on this pre-drying of the gasket 320, the device 105 may have a shelf stability exceeding a threshold of 12 months.
[0119] In other embodiments (not shown), to operatively couple the first part 110 and the second part 115, an adhesive may be placed between the first part 110 and the second part 115. In still further embodiments (not shown), the device 105 may include a single unitary piece, rather than two separate and operatively coupled pieces (such as the first part 110 and the second part 115).
[0120] In some embodiments, the gasket 320 forms a wall of each of the plurality of fluid chambers 205. When forming a wall, the gasket 320 can seal an opening at an end of the fluid chamber 205 and / or extend thereover. Thus, the gasket 320 and / or a portion thereof can define an end of the fluid chamber 205 and / or sealably contain one or more solid and / or fluid media (e.g., a biological sample and / or an optical property modifying reagent and / or an assay reagent) within the fluid chamber 205.
[0121] The gasket 320 according to the present theme embodiment can be or include a sheet (e.g., a solid sheet) of one or more materials (e.g., two materials) having a thin and / or planar shape. The gasket 320 may include a top surface and a bottom surface, each defining a plane parallel to each other and separated by a thickness. In various embodiments, the sheet is or includes a uniform layer of a single material. The gasket 320 may also be composed of two or more (e.g., three, four, five or more, etc.) sheets laminated to each other. In some versions, the sheet is an acrylic adhesive laminate.
[0122] In some aspects, the gasket 320 may have a length, a width, and a height (also referred to as a thickness). The thickness of the gasket 320 (e.g., the thickness between the first surface and the second surface opposite to the first surface) may be 5 mm or less, 3 mm or less, 1 mm or less, 0.5 mm or less, 0.1 mm or less, or 50 μm or less. The thickness of the gasket 320 and / or its sheet may also be, for example, in the range of 5 mm to 50 μm (such as 3 mm to 0.1 mm, such as 1 mm to 0.1 mm) (including end values). Moreover, the length and / or width of the gasket 320 and / or the sheet may also be in the range of 1 mm to 2 m (such as 1 cm to 1 m, such as 1 cm to 10 cm, such as 1 cm to 5 cm).
[0123] Spacer 320 may be and / or have an area defining any suitable size or shape including: circular, semicircular, oval, rectangular, square, triangular, polygonal, quadrilateral, or combinations thereof. Spacer 320 may include one or more sheets of solid, uniform, unitary material, and in some versions, spacer 320 does not include any openings therethrough.
[0124] The gasket 320 and / or its sheet may have three edges, four edges, or more than four edges that define the area of the gasket 320. In various embodiments, the edges intersect at corners (e.g., three, four, five, or ten or more corners). In some versions, the first edge of the gasket 320 is opposite the second edge of the gasket 320 and is adjacent to the third and / or fourth edge of the gasket 320. In such embodiments, the third edge may be opposite the fourth edge, and the fourth edge may be adjacent to the first and / or second edge.
[0125] According to the present subject embodiment, the gasket 320 can be made of a variety of materials. The sheets included in the gasket 320 can be made of the same or different materials. Such materials can have the characteristics of flexibility and / or high strength (e.g., wear resistance) and / or high fatigue resistance (e.g., being able to maintain its physical properties for a long time regardless of the amount of use or environment). The materials of interest that can constitute the gasket 320 or its part include, but are not limited to: polymer materials, for example, elastomeric rubbers, such as natural rubber, silicone rubber, ethylene-vinyl rubber, nitrile rubber, butyl rubber; plastics, such as polytetrafluoroethylene or polytetrafluoroethylene (PFTE), including expanded polytetrafluoroethylene (e-PFTE), polyester (DacronTM), nylon, polypropylene, polyethylene, high-density polyethylene (HDPE), polyurethane; or adhesives, such as acrylic adhesives, silicone adhesives, epoxy resin adhesives, or any combination thereof. As described, each of such materials can include a coating or layer of an adhesive material (e.g., an acrylic adhesive material) on one or more surfaces thereof.
[0126] In addition, in various cases, the gasket 320 or a portion thereof (such as, the first and / or second laminate layer) does not include an acid. In addition, in some versions, the gasket 320 or a portion thereof (such as, for example, the first and / or second laminate layer) is opaque and / or white. In the case where the gasket 320 or a portion thereof is white, the white layer provides a uniform background for optical inspection of one or more fluid chambers 205. In some versions, the layer (e.g., the first layer and / or the second layer and / or the gasket 320) is opaque and / or a color complementary to the reaction start color, for example, red, orange, yellow, green, blue, indigo, violet, black, gold, silver, brown, or any combination thereof. The reaction start color is the color of the reaction product and / or the optical property modifying reagent before the reaction occurs, wherein the reaction occurs to sufficiently modify the optical property of the optical property modifying reagent to allow detection of the modified optical property indicating the presence of the suspected analyte in the biological sample. A color complementary to the reaction starting color may provide sufficient color contrast of the fluid chamber 205, such as increased color contrast compared to a single color, such that, for example, the modified optical property is detectable by a sensor.
[0127] In various cases, the spacer 320 or a portion thereof is transparent to light (e.g., visible light). In other versions, the spacer 320 or a portion thereof is reflective, e.g., completely or substantially reflects light (e.g., visible light). In other versions, the spacer 220 is substantially opaque and light absorbing, e.g., having a black colorant. Additionally, as noted herein, the spacer 320 can include a first layer laminated to a second layer. In such embodiments, for example, the first layer does not include an acid, and / or the second layer is opaque and / or white.
[0128] Additionally, in various cases, the gasket 320 or a portion thereof (such as a sheet) has a thermal conductivity in a range of 0.1 W / mK to 10 W / mK (such as 0.1 W / mK to 5 W / mK, such as 1 W / mK to 5 W / mK).
[0129] According to some versions, gasket 320 is a patterned adhesive layer. In such embodiments, gasket 320 can be or have a porous and / or include one or more openings extending from a first surface of gasket 320 to a second surface of gasket 320 opposite to the first surface, so that the contents (e.g., liquid) in one or more fluid chambers 205 can pass therethrough. Thus, in some aspects, when performing an assay, one or more contents (e.g., liquid) of fluid chamber 205 can directly contact the substrate and / or one or more components thereof, such as a sensor and / or a heating element.
[0130] In addition to the gasket 320, Figure 3A Also depicted is a thermal pad 325 located below the second part 115. The thermal pad 325 includes an annular shape and is configured to transfer heat from a heating element (not shown) to the plurality of fluid chambers 205. The heat transferred by the thermal pad 325 is used to promote reactions occurring within the fluid chambers 205. Note that in some embodiments, the thermal pad 325 is not included in the device 105. In alternative embodiments (not shown), the thermal pad 325 can be a thermally conductive paste and / or thermally conductive tape.
[0131] The annular shape of the thermal pad 325 enables heat to be evenly transferred to each of the plurality of fluid chambers 205. This even distribution of heat flux provides consistent isothermal heating to each fluid chamber 205, thereby standardizing reaction conditions and enabling more accurate assays. Figures 8 to 10B The operation of the thermally conductive pad 325 and the heating element is discussed in more detail.
[0132] Figure 3A Also depicted is a dried or lyophilized reagent 330. As shown in reference Figure 1 As discussed, in some embodiments, a dried or lyophilized reagent 330 is contained within each fluid chamber 205. In some embodiments, the dried or lyophilized reagent 330 comprises an assay reagent. In other embodiments, the assay reagent comprises a nucleic acid amplification enzyme and a DNA primer. In such embodiments, the assay reagent effects amplification of a selected nucleic acid present or suspected of being present in a biological sample. The reagent 330 is dried or lyophilized in order to extend shelf stability of the reagent 330 and, therefore, the device 105. Fig.11 The dried or lyophilized assay reagents 330 located within the fluid chamber 205 are discussed in greater detail.
[0133] Figure 3Bis an illustration of a bottom view 300B of unattached components of a device 105 for performing a bioassay, according to an embodiment. In other words, Figure 3B supply Figure 3A An alternative view of the uncoupled components of the device 105 depicted in FIG.
[0134] Figure 3C is an illustration of an aerial view 300C of an alternative uncoupled component of a device 105 for performing a bioassay, according to an embodiment. Figure 3A and Figure 3B , Figure 3C The unconnected components of the device 105 depicted in FIG. 1 include the first part 110, the second part 115, the thermal pad 325, and the lyophilized reagent 330. However, instead of the pad 320, Figure 3C The device 105 depicted in includes a hydrophobic membrane 335 .
[0135] In some embodiments, the hydrophobic membrane 335 replaces both the gasket 320 and the self-sealing vent material discussed with reference to the outlet vent 135. Specifically, the hydrophobic membrane 335 is operatively coupled to the first part 110 and the second part 115 to provide a seal between the outlet vent 135 and the gasket 320. Figure 1 The continuous fluid path discussed forms a fluid seal. In addition, the hydrophobic membrane 335 seals the outlet vent 135 of each fluid chamber in the plurality of fluid chambers 205. In some embodiments, the hydrophobic membrane 335 is welded to the Figure 3A and Figure 3C . In certain embodiments, the hydrophobic membrane 335 comprises polytetrafluoroethylene. The hydrophobic membrane 335 can be pre-dried to a residual moisture between 0 and 0.4% w / w. Alternatively, the hydrophobic membrane 335 can be pre-dried to a residual moisture of at most 0.2% w / w. Based on this pre-drying of the hydrophobic membrane 335, the device 105 can have a shelf stability exceeding a threshold of 12 months.
[0136] In some embodiments, the energy director ( Figure 3E ) is used to weld the hydrophobic membrane 335 to one of the first part 110 and the second part 115. In such an embodiment, the energy director is located at Figure 3B and Figure 3D 10. Specifically, the energy director is located around the fluid channel 305 and the outlet vent 135 of the first part 110. In an alternative embodiment, rather than using an energy director, the hydrophobic membrane 335 is sealed in place relative to the first part 110 and the second part 115 using pressure, ultrasonic welding, adhesive materials, or thermal bonding.
[0137] In alternative embodiments, the device 105 may include both the gasket 220 and the hydrophobic membrane 335. For example, the gasket 220 and the hydrophobic membrane 335 may be laminated together, or the hydrophobic membrane 335 may be located on the top surface of the first part 110 and the gasket 220 may be located between the first part 110 and the second part 115.
[0138] Figure 3D 300D is an illustration of a bottom view of an alternative unattached component of a device 105 for performing a bioassay, according to an embodiment. Figure 3D As shown, a hydrophobic membrane 335 has replaced the gasket 320 and the self-sealing vent material covering the outlet vent 135 .
[0139] In an alternative embodiment (not shown), a self-sealing vent may be used to cover the outlet vent 135 without using a gasket 320. In such an embodiment, the first part 110 and the second part 115 may be coupled using ultrasonic welding, an adhesive, or thermal bonding.
[0140] Figure 3E is an illustration of a cross-section 300E of an apparatus 105 for performing a bioassay according to an embodiment. Specifically, Figure 3E Depicted is a first part 110 operatively coupled to a second part 115 via a hydrophobic membrane 335 and an energy director 340. Figure 3E In the embodiment depicted in , the hydrophobic membrane 335 has been welded to the first part 110 and the second part 115 using energy directors 340 to form a plurality of continuous fluid paths.
[0141] in addition, Figure 3E Lyophilized reagent 330 is depicted within fluid chamber 205 .
[0142] Optical property testing
[0143] Figure 4 is an illustration of a cross-section of a second part 115 of a device 105 for performing a bioassay according to an embodiment. Figure 4 As depicted, the second part 115 of the device 105 is configured to enable detection of modified optical properties of the reaction mixture contained within the plurality of fluid chambers 205. Specifically, the second part 115 includes a sensing region 215, a photoelectric sensor 405, Figure 1 , and a plurality of first light pipes 210 as depicted in FIG.
[0144] The sensing region 215 is an optical property analysis region. As described above with respect to the fluid chambers 205, in certain embodiments, the sensing region 215 may be substantially equidistant from each of the plurality of fluid chambers 205. In certain embodiments, this means that the sensing region 215 is located at or near the center of the device 105. In some aspects, the central region is defined relative to the location of the plurality of fluid chambers 205. By positioning the sensing region 215 so that it is substantially equidistant from each of the plurality of fluid chambers 205, the optical properties of the reaction mixture contained within each fluid chamber 205 may be accurately and precisely detected at the sensing region 215 under the same parameters. As used herein, "substantially equidistant" means that the distance of each of the plurality of fluid chambers from a single sensing region does not differ by more than + / - 25% from the distance of each of the other fluid chambers from the single sensing region in the plurality of fluid chambers.
[0145] In some embodiments, the photosensor 405 is optically coupled to the first plurality of light pipes 320 and is located within the sensing region 215. The photosensor 405 detects a modification of an optical property of the reaction mixture contained within each fluid chamber 205. For example, the photosensor 405 can be configured to detect a color change of the reaction mixture contained within the fluid chamber 205. In an alternative embodiment, the photosensor 405 can be configured to detect a change in absorbance of the reaction mixture contained within the fluid chamber 205. The photosensor 405 can include one of a CMOS chip, a photodiode, a phototransistor, a photocell, and a photomultiplier tube.
[0146] To enable the photosensor 405 to detect the modified optical properties of the reaction mixture within the fluid chamber 205, the plurality of light emitting elements 410 transmit light through the reaction mixture within the fluid chamber 205 and into the sensing region 215 containing the photosensor 405. To achieve this passage of light from the light emitting elements 410 to the sensing region 215 of the second part 115, the light emitting elements 410 are positioned around the second part 115 near the fluid chamber 205 such that the fluid chamber 205 is positioned between the light emitting elements 410 and the photosensor 405 in the sensing region 215. Specifically, each of the plurality of light emitting elements 410 is positioned to illuminate one of the plurality of fluid chambers 205. In some embodiments, the light emitting elements 410 are radially arranged around the second part 115 and / or around the sensing region 215. In some embodiments, the light emitting elements 410 include LEDs. In alternative embodiments, the light emitting elements 410 may include lasers.
[0147] In addition to the light emitting element 410, the second part 115 also includes a plurality of first light pipes 210 and a plurality of second light pipes 140 that enable light from the light emitting element 410 to travel to the sensing area 215. Specifically, each of the plurality of second light pipes 140 is located between the light emitting element 410 and the fluid chamber 205. Thus, the second light pipe 140 enables light to travel from the light emitting element 410 to the fluid chamber 205. In addition, each of the plurality of first light pipes 210 is located between the fluid chamber 205 and the sensing area 215. Thus, the first light pipe 210 enables light to travel from the fluid chamber 205 to the sensing area 215, which can be detected by the photosensor 405. For example, Figure 4 Light 415 is shown traveling from the light emitting element 410 through the second light conduit 140 into the fluid chamber 205 , through the first light conduit 210 and into the sensing region 215 containing the photosensor 405 .
[0148] In certain embodiments, the second light pipe 140 and / or the first light pipe 210 may include a reflective surface 420A, a reflective surface 420B, and / or one or more refractive surfaces (not shown) to allow light 415 to travel from the light emitting element 410 through the second light pipe 140 into the fluid chamber 205, through the first light pipe 210, and into the sensing region 215. In certain embodiments, the reflective surfaces 420A and 400B are oriented at a 45 degree angle relative to the normal. In alternative embodiments, the reflective surfaces 420A and 400B may be oriented at alternative angles relative to the normal. In further embodiments, the reflective surfaces 420A and 420B may be placed within the second light pipe 140 and the first light pipe 210 in addition to Figure 4 at alternative locations other than those depicted in . Figure 5 and Figure 6 Refractive surfaces are discussed in more detail. In other embodiments (not shown), the first light pipe 210 and the second light pipe 140 may include optical filters to achieve wavelength selectivity.
[0149] In some embodiments, the second part 115 or a portion thereof is transparent to light (e.g., visible light). For example, in certain embodiments, the first light pipe 210 and / or the second light pipe 140 may be transparent to visible light. Thus, a user may observe the modification of the optical property of a sample or an aspect thereof through the second part 115. In addition, the transparency of the second part 115 facilitates the detection of the optical property by the photosensor 405. Examples of materials that constitute the second part 115 and achieve the transparency of the second part 115 may include polymethyl methacrylate, polystyrene, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, cyclic olefin copolymer, polyamide, and combinations thereof.
[0150] As mentioned above about Figure 1 and FIG. 2A to FIG. 2F As discussed, in some embodiments, each fluid chamber 205 in the plurality of fluid chambers is substantially equidistant from the sensing region 215. As used herein, "substantially equidistant" means that the distance of each fluid chamber in the plurality of fluid chambers from the single sensing region differs by no more than + / -25% from the distance of each other fluid chamber in the plurality of fluid chambers from the single sensing region. In addition, because the first light guide pipe 210 is located between the fluid chamber 205 and the sensing region 215, in such embodiments, each first light guide pipe in the first plurality of light guide pipes 210 has the same length between the fluid chamber 245 and the sensing region 215. In other words, the optical path length between each fluid chamber 245 and the sensing region 215 is similar or equal. This similarity in optical path length is advantageous because it allows the device 105 to perform multiple assays in parallel under the same specifications. This in turn achieves more accurate and controlled assay results. A preferred way to achieve this similarity in optical path length is to design the device 105 to be radially symmetrical. In other embodiments, each first light pipe in the first plurality of light pipes 210 has the same dimensions. This further enables the apparatus 105 to perform multiple controlled assays in parallel.
[0151] The at least substantial radial symmetry of the device 105 including the second part 115 enables centralization of certain components of the device 105, which in turn enables a reduction in the number of such components, thereby reducing the manufacturing cost of the device 105. Specifically, by placing a single photosensor 405 in the sensing region 215, the single photosensor 405 is capable of detecting changes in the optical properties of the reaction mixture within each of the plurality of fluid chambers 205. This use of a single centralized photosensor 405 is advantageous because it limits the number of photosensors used by the device 105, thereby limiting the overall cost of the device 105. Furthermore, because photosensors are relatively expensive components compared to other components of the second part 115, centralizing the single photosensor 405 in the sensing region 215 is a relatively more cost-effective arrangement of components of the second part 115 compared to alternative arrangements of the second part 115. For example, because photosensors are generally more expensive than light emitting elements 410, centralizing the single photosensor 405 in the sensing region 215 is relatively more cost-effective than centralizing the single light emitting element 410 in the sensing region 215. Furthermore, the device 105 includes no moving parts and is therefore less bulky and less prone to failure than devices that do include moving parts, such as mirrors and fluid chambers.
[0152] In addition to reducing costs by using a single photosensor 405, the first part 110 and the second part 115 are both unitary parts that are multifunctional components because when operatively coupled (optionally, coupled with additional components such as the gasket 220), the first part 110 and the second part 115 can each individually form the components of the device 105 required to perform a bioassay. Therefore, the simplicity and reduction in the number of individual components of the device 105 also reduces the overall cost of the device 105.
[0153] In order to use a single photosensor 405 to detect the optical properties of multiple reaction mixtures located in multiple fluid chambers 205 through multiple light rays 415 originating from multiple light emitting elements 410, multiple light emitting elements 410 emit light in a repetitive pattern at a specific repetition frequency, so that only one of the multiple fluid chambers 205 is illuminated at any time. In this way, the photosensor 405 is able to detect the optical properties of each of the multiple reaction mixtures at different times, thereby achieving accuracy in the detection of the optical properties of each reaction mixture. In addition, since each of the multiple fluid chambers 205 is individually illuminated during each repetition of the pattern, the optical properties of each of the multiple reaction mixtures are continuously monitored at a specific repetition frequency. In certain embodiments, the repetition frequency is in the range of 0.01 to 100 Hz. The control of the repetition frequency of the light emitting element 410 is referred to below Figure 8 and Fig. 9 Discuss in more detail.
[0154] Figure 5 is an illustration 500 of a cross-section of an apparatus 105 for performing a bioassay 105 according to an embodiment. Specifically, Figure 5 Depiction Figure 4 An alternative view of the detection of optical properties is shown. Figure 4 The reflective surface 420A located in the second light pipe 140 and the reflective surface 420B located in the first light pipe 210 can be used to guide the light 415 from the light emitting element 410 to the photosensor 405 in the sensing area 215 .
[0155] Figure 5 Also depicted is a refractive surface 505. The refractive surface 505 is located within the first light pipe 210 and changes the angle at which the light ray 415 enters the sensing region 215. In alternative embodiments, the refractive surface 505 may be placed within the first light pipe 210 in addition to Figure 4 In addition, in alternative embodiments, the refractive surface 505 can be located within the second light pipe 140.
[0156] Figure 6 is an image 600 of a ray tracing simulation 605 of light rays 415. Specifically, Figure 6Light ray 415 is depicted traveling from light emitting element 410 through second light conduit 140 into fluid chamber 205 , through first light conduit 210 , and into sensing region 215 .
[0157] Note that in this process of traveling from the light emitting element 410 to the sensing area 215, the light ray 415 reflects and refracts off of various surfaces. For example, the light ray 415 reflects off of a reflective surface 420A located within the second light pipe 140. In some embodiments, the reflective surface 420A can be oriented at a 45 degree angle relative to the normal. Additionally, the light ray 415 reflects off of a reflective surface 420B located within the first light pipe 210. In some embodiments, the reflective surface 420B can also be oriented at a 45 degree angle relative to the normal.
[0158] In addition to reflecting off of reflective surfaces 420A and 420B, light ray 415 may also be refracted off of refractive surface 505. For example, Figure 6 As depicted in FIG. 4 , the light 415 is refracted away from the refractive surface 505 located within the first light pipe 210 and then enters the sensing region 215 .
[0159] Figure 7 7 is an image 700 of ray tracing simulation results 705, which shows the optical intensity at the sensing area 215 for the ray tracing simulation 605. Specifically, Figure 7 The radiation measurement over the entire sensing area 215 is depicted. The photosensor 405 is located at or near the center of the sensing area 215. Specifically, the photosensor 405 is approximately located at the coordinates of x=0, y=0. Figure 7 As shown, the peak radiation is focused around the location of photosensor 405 at x = 0, y = 0. This indicates that light 415 is primarily focused on photosensor 405, thereby enabling accurate detection of the optical property transmitted by light 415.
[0160] system
[0161] Figure 8 is a diagram 800 of a system 805 for performing a bioassay according to an embodiment. The system 805 includes the above reference Figures 1 to 7 The described device 105. As mentioned above with reference Figures 1 to 7 As discussed, in some embodiments, the device 105 includes a first part 110, a second part 115, a gasket 320, a sensing area 215, a photosensor 405, a light-emitting element 410, an outlet vent material 810 for covering the outlet vent 135 of the device 105, and a lyophilized reagent 330 contained within the fluid chamber 205. Figure 8 Describe these parts.
[0162] In addition to the components of the device 105, the system 805 includes additional components. Specifically, the system 805 includes a circuit board 815, a microprocessor 820, a heating element 825, a temperature sensor 830, an electronic result display mechanism 835, a power supply 840, a housing top 845, a housing base 850, a sample preparation tube orifice 855, a sample preparation tube 860, an electronic result display orifice 865, and a power supply cover 870.
[0163] In some embodiments, the circuit board 815 comprises a printed circuit board comprised of layers, such as fiberglass and / or copper and / or gold and / or aluminum contacts therein or thereon. For example, the circuit board 815 can be a printed circuit board comprised of layers, such as fiberglass layers, having metal contacts attached thereto by one or more adhesives (e.g., epoxy). In certain embodiments, the fluid chamber 205 of the device 105 can be operably coupled to the circuit board 815. For example, the device 105 can be operably coupled to the circuit board 815 using an adhesive layer (not shown).
[0164] In certain embodiments, the microprocessor 820, the heating element 825, the temperature sensor 830, and the electronic result display mechanism 835 are also coupled to the circuit board 815. The coupling of the microprocessor 820, the heating element 825, the temperature sensor 830, and the electronic result display mechanism 835 to the circuit board 815 may include mechanical and / or electrical coupling.
[0165] The microprocessor 820 is configured to generate one or more outputs (e.g., electrical signals) based on one or more sets of inputs (e.g., inputs from a user and / or sensors and / or timers, and / or instructions stored in a memory of the microprocessor 820). The system 805 may also include a user interface for receiving inputs and operatively coupled to the microprocessor 820. The microprocessor 820 may be electrically coupled to the light emitting element 410, the photosensor 405, the heating element 825, the temperature sensor 830, and / or the electronic result display mechanism 835. The functionality of the microprocessor 820 with respect to each of these components is discussed in more detail below.
[0166] Examples of such heating elements 825 include conductors undergoing resistive Joule heating, thermoelectric heat pumps such as Peltier elements, chemical heating agents undergoing exothermic reactions, or other elements that generate heat.
[0167] The heating element 825 comprises an annular shape and is configured to heat the plurality of fluid chambers 205 and their contents to promote reactions occurring within the fluid chambers 205. Thus, the heating element 825 is located below the second part 115 of the device 105 so that the heating element 825 can transfer heat to the fluid chambers 205. In some embodiments, the heating element 825 is located between the circuit board 815 and the second part 115 of the device 105. In other embodiments, the heating element 725 is a conductive trace on the circuit board 715. In other embodiments, the heating element 725 is comprised of a resistive element (e.g., a surface mount resistor) attached to the circuit board 715.
[0168] The heating element 825 may be configured to increase the temperature of the fluid chamber 205 and / or its contents (e.g., biological sample) by 1°C. The heating element 825 may also be configured to increase the temperature of the fluid chamber 205 and / or its contents from room temperature (e.g., 21°C) to a maximum of 90°C and / or within a range of 90°C in 10 minutes or less. For example, the heating element 825 may be configured to increase the temperature of the fluid chamber 205 and / or its contents from room temperature to 63°C ± 1°C in 3 minutes or less, and / or may be configured to maintain such a temperature for 30 minutes or more. The heating element 825 may also be configured to maintain the temperature of the fluid chamber 205 and / or its contents for a certain period of time, such as 2 hours or more, or 2 hours or less. Such a temperature may be maintained at a maximum of 90°C and / or within a range of 90°C. Maintaining such a temperature is performed by applying a thermistor (such as, temperature sensor 830) and / or is based on sensor feedback to microprocessor 820 (such as, microprocessor 820). The heating element 825 is configured to repeatedly raise the temperature of the fluid chamber 205 and / or its contents, for example, heating the contents once and then heating the contents twice. The heating element 825 can also heat the contents of the fluid chamber 205 so that optical property modification and / or nucleic acid amplification occurs. In addition, the heating element 825 can heat the contents to perform thermal cycles for amplification reactions such as PCR. In these cases, it may be advantageous to configure the heating element to, for example, use a polarity reversible thermoelectric heat pump to both heat and actively cool the reaction chamber.
[0169] As previously referenced Figure 3A As discussed, the device 105 may also include a thermally conductive pad 325 (not shown) between the heating element 825 and the second part 115. As noted above, the thermally conductive pad 325 includes an annular shape and is configured to transfer heat from the heating element 825 to the fluid chamber 205.
[0170] As also discussed above, the annular shape of the heating element 825 enables heat to be evenly transferred to each of the plurality of fluid chambers 205. This even distribution of heat flux provides consistent isothermal heating to each fluid chamber 205, thereby standardizing reaction conditions and enabling more accurate assays. Fig. 10A and Fig. 10B The functionality of heating element 825 is discussed in more detail.
[0171] As mentioned above with respect to the heating element 825, the temperature sensor 830 can measure the temperature of the heating element 825, the fluid chamber 205, and / or the contents of the fluid chamber 205. These measurements can then be relayed to the microprocessor 820 and used by the microprocessor 820 to control the temperature of the heating element 825, thereby controlling the temperature of the fluid chamber 205 and / or the contents of the fluid chamber 205.
[0172] In some embodiments, microprocessor 820 can be programmed to cause each of plurality of light emitting elements 410 to emit light in a repeating pattern at the specified repetition frequency described above, wherein only one of plurality of fluid chambers 205 is illuminated at any time during the repeating pattern.
[0173] In other embodiments, the microprocessor 820 can be programmed to analyze the signals received from the photosensor 405. Specifically, the microprocessor 820 can be programmed to perform optical property modification and / or colorimetric analysis on the biological sample in the fluid chamber 205 based on the signals received from the photosensor 405. Thus, the microprocessor 820 can be configured to determine whether a change in an optical property (e.g., color) of one or more contents of the fluid chamber 205 has occurred based on input from the photosensor 405.
[0174] Based on the determination, the microprocessor 205 may then generate signals for transmission to an electronic result display mechanism 835. These signals may include the results of the biometric assay based on the optical properties analyzed by the microprocessor 820. In some embodiments, the electronic result display mechanism 835 provides visual and / or audio results of the biometric assay in a simple and concise manner. In other embodiments, the results are transmitted to a receiving electronic device, such as a server, a personal computer, or a handheld smart phone.
[0175] In some cases, the system 805 includes one or more power supplies 840. The power supply 840 is operably connected to the circuit board 815, and is therefore operably connected to any component (e.g., photoelectric sensor 405, light emitting element 410, microprocessor 820, heating element 825, temperature sensor 830, and electronic result display mechanism 835) to which the circuit board 815 is coupled. In some aspects, the power supply 840 may include, for example, one or more batteries, direct current (DC) power supply, alternating current (AC) power supply, linear regulation power supply, and / or switch mode power supply. For example, in some aspects, the power supply 840 may be one or more batteries, such as portable and / or self-contained and / or replaceable batteries, such as one or two AA batteries, sockets, or another power source. The amount of power, current, and / or voltage that can be provided by the power supply 840 may, for example, be roughly equal to the amount of powering the photoelectric sensor 405, light emitting element 410, microprocessor 820, heating element 825, temperature sensor 830, and electronic result display mechanism 835. In some aspects, the power supply 840 can include one or more cords, for example, a cord configured to operatively connect the system 805 to an outlet. The cord of the power supply 840 can be configured to be removably connected to the system 805 and / or an outlet.
[0176] The power supply 840 is configured to be turned on to provide power to one component and / or turned off to stop providing power to another component. The power supply 840 can be configured to be turned on and / or off, for example, by operating a switch, a button, a timer, or other components operatively connected to or included in the power supply 840 (such as, microprocessor 820).
[0177] In certain embodiments, the device 105 (including the first part 110, the second part 115, the sensing area 215, the photosensor 405, the light emitting element 410, the outlet vent material 810, and the lyophilized reagent 330), the circuit board 815, and all the components to which the circuit board 815 is coupled (including the microprocessor 820, the heating element 825, the temperature sensor 830, and the electronic result display mechanism 835), and the power supply 840 can be stored within the housing. The housing can include a housing top 845, which can be operatively coupled, such as matable, such as snap-coupled, to the housing base 850. When operatively coupled, the housing top 845 and the housing base 850 are configured to contain (e.g., completely contain) the device 105, the circuit board 815, and all the components to which the circuit board 815 is coupled, and the power supply 840.
[0178] As described herein, housing top 845 and housing bottom 850 may be constructed from one or more layers of material (eg, a polymer material) and may be shaped substantially as a rectangular box.
[0179] In some embodiments, housing top 845 may include electronic result display aperture 860. Electronic result display aperture 860 is an opening that provides visual access to electronic result display mechanism 835 so that a user of system 805 can view signals displayed by electronic result display mechanism 835.
[0180] In other embodiments, the housing top 845 may include a sample preparation tube orifice 850. The sample preparation tube orifice 850 is an opening configured to receive a sample preparation tube 855. The sample preparation tube orifice 850 provides a channel (e.g., a fluid channel) leading to the common sample receiving inlet 130 of the device 105, so that the biological sample can pass therethrough to be loaded into the common sample receiving inlet 130. Specifically, the biological sample is loaded into the sample preparation tube 855, passes through the sample preparation tube orifice 850, and enters the common sample receiving inlet 130. In certain embodiments, in addition to the biological sample, additional reagents may also be loaded into the sample preparation tube 855. For example, an optical property modifying reagent solution including an optical property modifying reagent and a liquid buffer may be loaded into the sample preparation tube 855 together with the biological sample. Reference Fig.11 Such embodiments are discussed in more detail.
[0181] In certain embodiments, the housing base 850 includes a power supply cover 870. The power supply cover 850 is configured to protect the power supply 840 and provide access thereto.
[0182] According to some embodiments, system 805 and its components are handheld devices or components. As used herein, the term "handheld" refers to the characteristic ability of an aspect to be held (e.g., held, or easily or comfortably held) in a hand (such as a mammal's hand, such as a human hand, such as an adult male or female human hand of average size and / or strength). Thus, a handheld aspect is an aspect that is sized and / or shaped to be held (e.g., easily or comfortably held) in a human hand. A handheld aspect can also be an aspect that is movable (e.g., easily moved, such as easily moved in a vertical and / or horizontal direction) by a human (e.g., one or both hands of a human).
[0183] Ideally, system 805 would be cheap enough to be disposable, thereby simplifying use and eliminating the need for maintenance and cleaning.
[0184] Fig. 9 is a block diagram 900 depicting the interactions between powered components of system 805 according to an embodiment. Specifically, Fig. 9 Depicts the interaction between power source 840 and the components of system 805 powered by power source 840. Fig. 9In the embodiment depicted in FIG, the circuit board 815 and the components connected to the circuit board 815 are powered by a power source 840. Fig. 9 As shown, the components coupled to the circuit board 815 include the photosensor 405, the light emitting element 410, the microprocessor 820, the heating element 825, the temperature sensor 830, and the electronic result display mechanism 835. In alternative embodiments, alternative components may be coupled to the circuit board 815. For example, in certain embodiments, the temperature sensor 825 and / or the electronic result display mechanism 835 may not be coupled to the circuit board 815.
[0185] The power supply 840 provides power to the circuit board 815. This power is delivered from the circuit board 815 to the components to which the circuit board 815 is coupled. For example, power is delivered from the circuit board 815 to the photosensor 405, the light emitting element 410, the microprocessor 820, the heating element 825, the temperature sensor 830, and / or the electronic result display mechanism 835. The microprocessor 820 in turn provides instructions to the power supply 840 regarding the power specifications required to operate the components coupled to the circuit board 815 at a particular moment.
[0186] The microprocessor 820 also provides operating instructions to certain components coupled to the circuit board 815. For example, the microprocessor 820 provides heating instructions to the heating element 825. The heating instructions detail the specifications of the amount of heat required to heat the contents of the fluid chamber 205 based on a specified heating scheme. In certain embodiments, the heating instructions provided by the microprocessor 820 to the heating element 825 may be based on temperature information obtained by the temperature sensor 830 and transmitted to the microprocessor 820.
[0187] The microprocessor 820 may also provide lighting instructions to each of the plurality of light emitting elements 410. The lighting instructions may specify a repeating pattern in which the light emitting elements 410 are illuminated and / or a frequency at which the repeating pattern is repeated.
[0188] The photoelectric sensor 405 can use the light emitted by the light emitting element 410 to capture optical information about the contents contained within the fluid chamber 205. For example, the optical information can include information about the optical properties of the contents contained within the fluid chamber 205. This optical information can then be sent to the microprocessor 820. The microprocessor 820 analyzes these optical signals and generates one or more assay results. These results can be sent by the microprocessor 820 to an electronic result display mechanism 835, where the results are simply and clearly provided to a user of the system 805.
[0189] Fig. 10A is a thermal image 1000A of a heating element 825 according to an embodiment. Figure 3A , Figure 3B and Figure 8As depicted, the heating element 825 includes an annular shape such that the contents of each fluid chamber in the plurality of fluid chambers 205 can receive a uniform heat flux from the heating element 825. Fig. 10A As shown, the temperature of the heating element 825 is relatively uniform across the entire area covered by the heating element 825.
[0190] Fig. 10B 1 is a bar graph 1000B depicting average temperature measurements of each of the plurality of fluid chambers 205 when heated by the heating element 825, according to an embodiment. Specifically, the bar graph 1000B shows that the average temperature of each fluid chamber 205 is similar. For example, the average temperature of the plurality of fluid chambers 205 is in the range of 59.7° C. to 62.9° C. Therefore, the average temperature of each of the plurality of fluid chambers 205 is relatively uniform.
[0191] method
[0192] The present disclosure includes methods for modifying optical properties in biological sample assays. Such modifications can be performed on biological samples, or aspects associated therewith (such as reaction mixtures or reaction products). Where desired, the modification of optical properties can be performed using biological sample assay optical property modification devices and / or systems (such as the devices 105 and systems 805 described herein).
[0193] Fig.11 is a flow chart of a method 1100 for performing a bioassay using system 805 according to an embodiment. In other embodiments, the method may include Fig.11 In addition, in various embodiments, the steps of the method can be combined with Fig.11 The described sequence may be executed in a different order.
[0194] The subject provides 1101 a biological sample. Figure 1 As described, a biological sample is a sample comprising an amount of organic material (e.g., one or more organic molecules, such as one or more nucleic acids, such as DNA and / or RNA or portions thereof) that can be obtained from a subject. In some aspects, the biological sample is a nucleic acid amplification sample, which is a sample suspected of comprising one or more nucleic acids or portions thereof that can be amplified.
[0195] The biological sample provided may include one or more cells, such as tissue cells of a subject. As used herein, the term "tissue" refers to one or more cell aggregates or multiple different types of such aggregates in a subject (e.g., a living organism, such as a mammal, such as a human) having similar functions and structures. Tissues may include, for example, organ tissue, muscle tissue (e.g., cardiac muscle; smooth muscle; and / or skeletal muscle), connective tissue, neural tissue, and / or epithelial tissue. In some versions, tissues may include cells from the inside of a subject's cheek and / or cells in a subject's saliva.
[0196] The provided biological sample may include, for example, human saliva, urine, human mucus, blood, or solid tissue such as cheek tissue. The biological sample may also include bacteria or spores. The biological sample may be provided by a sample collector. Providing may include contacting (e.g., rubbing and / or scraping) the sample collector against one or more surfaces of the subject and / or the surface of the subject's biological sample (such as, a liquid (e.g., saliva and / or blood) sample extracted from the subject). Thus, in some versions, providing includes extracting one or more biological samples from the subject. In some versions, providing a biological sample may include instructing the subject to produce a biological sample, such as by spitting on and / or in the sample collector. Providing a biological sample may also include, for example, while transferring the sample collector to the device 105, keeping the biological sample or a portion thereof (e.g., one or more cells) on the sample collector. In some cases, the sample collector is a swab, and providing a biological sample includes wiping the subject's mouth and / or nose to obtain a biological sample on the collector. In some versions, the sample collector is a nasopharyngeal, middle turbinate, genital and / or nasal swab. After providing the biological sample, method 1100 may include processing the biological sample such that it becomes a prepared biological sample.
[0197] The prepared bioassay sample is, for example, a biological sample that has been treated by exposing the sample to a preparation solution, such as a solution comprising a lysing agent, such as a detergent. Thus, in some embodiments, the biological sample is a lysate. Such preparation enables the prepared biological sample to react with, for example, an assay reagent and / or an optical property modifying reagent when exposed to it. The exposure may include lysing the cells of the sample with a lysing agent of the preparation solution and / or extracting nucleic acids therefrom. Such extracted nucleic acids may be released into the resulting prepared sample solution. In some embodiments, a step of extracting genomic deoxyribonucleic acid (DNA) from the biological sample is included.
[0198] A user of the system 805 combines 1102 a provided biological sample with an optical property modifying reagent solution to produce a sample solution. In some embodiments, the optical property modifying reagent solution includes an optical property modifying reagent and a liquid buffer.
[0199] Optical property modifying agents may include, for example, pH sensitive dyes, fluorescent dyes, FRET dyes, micro- and nanoparticles, fluorescent proteins, colorimetric substrates, enzymes and reagents, plasmonic structures, precipitants and substrates, or any combination thereof.
[0200] In some versions, the optical property modification reagent is or includes an enzyme-linked immunosorbent assay (ELISA) reagent. In some aspects, the ELISA reagent is selected from the group consisting of alkaline phosphatase, horseradish peroxidase, β-galactosidase, BCIP / NBT (5-bromo-4-chloro-3-indolyl phosphate / nitro blue tetrazolium), TMB (3,3',5,5'tetramethylbenzidine), DAB (3,3',4,4'diaminobenzidine), 4CN (4-chloro-1-naphthol). TMB (bifunctional substrate), ABTS (2,2'-azido-bis[3-ethylbenzothiazoline]sulfonate), OPD (o-phenylenediamine), MUG (4-methylumbelliferyl galactoside), HPA (hydroxyphenylacetic acid) and HPPA (3-p-hydroxyphenylpropionic acid).
[0201] In various cases, the optical property modifying agent may include one or more optical property modifying substances and thus be configured such that one of its optical properties (eg, color) is modified. Thus, method 1100 includes modifying one or more optical properties of the optical property modifying agent.
[0202] Modifying an optical property refers to changing one or more optically identifiable characteristics of an aspect (e.g., a sample), such as characteristics of the wavelength and / or frequency of radiation (e.g., light) emitted from an aspect (e.g., color, fluorescence, phosphorescence, etc.). For example, in some versions, the optical property is color, and modifying the optical property includes changing the color. In some aspects, such optical property modifications (e.g., color changes) are detectable by an unassisted human eye, for example, under ambient light. In alternative aspects such as method 1100, the optical property modifications are detectable using a photoelectric sensor such as photoelectric sensor 405. Modifying an optical property may also include changing the transmittance and / or opacity of a substance, and may include causing a substance to substantially change from transparent to opaque or from opaque to transparent. Thus, method 1100 may include detecting such changes in transmittance using photoelectric sensor 405.
[0203] The user inserts 1103 the sample solution into the common sample receiving inlet 130 of the device 105 of the system 805. Figure 8 As described, inserting 1103 the sample solution into the common sample receiving inlet 103 may also include inserting the sample solution into a sample preparation tube 855 of the system 805 .
[0204] The system 805 transfers 1104 the sample solution into the fluid chamber 205. Specifically, the system 805 transfers 1104 a portion of the sample solution from the common sample receiving inlet 130 to the plurality of extended fluid channels 305, and from the ends of the plurality of fluid channels 310 to the fluid inlets 315 of the plurality of fluid chambers 205, wherein the fluid chambers 205 include assay reagents, thereby generating a nucleic acid reaction mixture.
[0205] Transporting the sample solution may include moving (e.g., causing it to flow) the sample solution to one or more fluid chambers in the plurality of fluid chambers 205. Such flow may include biasing (e.g., pumping) the sample solution to move through the fluid channel 310. Because the common sample receiving inlet 130 is substantially equidistant from each of the plurality of fluid chambers 205, the distance that the sample solution travels from the common sample receiving inlet 130 to each fluid chamber 205 is approximately equal. Therefore, the amount of time that the sample solution takes to travel from the common sample receiving inlet 130 to each fluid chamber 205 is approximately equal. This enables the system 805 to perform multiple controlled assays in parallel.
[0206] As noted above, in some embodiments, each of the fluid chambers 205 includes an assay reagent. Thus, transferring the sample solution to one or more of the fluid chambers 205 may include mixing the sample solution with the assay reagent, thereby generating a nucleic acid reaction mixture including the sample solution and the assay reagent to perform a nucleic acid amplification reaction.
[0207] The assay reagents include an enzyme and a nucleic acid primer capable of reacting with a biological sample so that one or more nucleic acids suspected of being present in the sample can be amplified, such as isothermally amplified (if present). In certain embodiments, the assay reagents include a nucleic acid amplification enzyme and a DNA primer. For example, the assay reagents may include one or more primers, deoxynucleotides (dNTPs) and / or a polymerase, Trizma pre-set crystals (Tris buffer, pH 8.8; Sigma, catalog number T9443), potassium chloride (KCl; Wako Pure Chemicals, catalog number 163-03545), magnesium sulfate heptahydrate (MgSO4; Wako Pure Chemicals, catalog number 137-00402), ammonium sulfate ((NH4)2SO4; Kanto Chemical, catalog number 01322-00), Tween 20 (Tokyo Chemical Industry, catalog number T0543), betaine solution (betaine, 5M; Sigma, catalog number B0400), calcein (DOJINDO, catalog number 340-00433) plus one or more optical modification agents as discussed above, manganese (II) chloride tetrahydrate (MnCl2; Wako Pure Chemicals, catalog number 163-03545), Chemicals, catalog number 133-00820), agarose S, EtBr solution, template nucleic acid, or any combination thereof. In addition, in some versions, the assay reagent can be stored in a dry (e.g., lyophilized) form in fluid chamber 205. Thus, preparing the reaction mixture can include mixing the sample solution and the assay reagent and / or hydrating the assay reagent.
[0208] The assay reagents may include one or more reagents capable of amplifying nucleic acids present in a biological sample by an isothermal amplification scheme, wherein the isothermal amplification scheme includes: transcription-mediated amplification, strand displacement amplification, nucleic acid sequence-based amplification, rolling circle amplification, loop-mediated isothermal amplification, isothermal multiple displacement amplification, helicase-dependent amplification, circular helicase-dependent amplification, single primer isothermal amplification, loop-mediated amplification, or any combination thereof.
[0209] In certain embodiments, the amplification reaction performed is LAMP. In the LAMP reaction, two or three pairs of primers are used to amplify the double-stranded or single-stranded DNA template in dynamic equilibrium at high temperature. Primers are designed based on DNA templates by using primer design software such as LAMP Designer (Premier Biosoft, Palo Alto, CA). In the first step of the LAMP reaction, the F2 region of FIP (forward inner primer) anneals to single-stranded DNA at the corresponding complementary (F2c) position. Next, a polymerase with strand displacement activity is incorporated into dNTPs from the 3' end of F2 along the template. The incorporation of nucleotides releases protons, thereby reducing the pH of the reaction mixture. Then, the F3 forward primer anneals to the F3c region upstream of the F2 region and on the template. The F3 forward primer begins to amplify the template chain, which releases more protons and displaces the previously synthesized FIP incorporation chain. This single strand comprises an F1 sequence (in the target sequence) and its complementary F1c sequence (in FIP). This forms a stem loop when F1c anneals to F1 at the 5' end. At the same time, BIP (reverse inner primer) anneals to the other end of the chain, and nucleotides extend from B2, releasing more protons. Reverse primer B3 then binds to the B3c region downstream of the B2 region, displacing the BIP amplified chain and promoting extension to form a double strand. This displaced chain now contains the B1 sequence (within the target sequence) and its complementary B1c sequence (within the BIP), forming another stem loop at the 3' end. The structure now has two stem loop structures at each end, from which continuous displacement and extension occur to amplify the template. The LAMP reaction can be amplified by adding more forward and reverse loop primers to produce more amplicons with stem loop structures.
[0210] The LAMP procedure can be performed at a fixed temperature, thereby minimizing the need for any expensive thermal cycling equipment. Typically, isothermal methods require a set temperature, which is determined by the selected reagents. For example, in the LAMP method, the enzyme works best between 60°C and 65°C. Amplification according to embodiments of the present invention can also be performed by applying PCR.
[0211] In some embodiments, the system 805 heats the reaction mixture 1105 to produce amplified nucleic acids and a plurality of protons. Specifically, the reaction mixture is heated using the heating element 825 to promote a nucleic acid amplification reaction using nucleic acids from a biological sample and an assay reagent. This reaction produces amplified nucleic acids and a plurality of protons.
[0212] In some embodiments, the heating step 1105 includes transferring heat energy from the heating element 825 to the thermal pad 325 and thereby to the one or more fluid chambers 205. Heating the reaction mixture promotes an amplification reaction between the nucleic acid of the biological sample and the nucleic acid of the assay reagent. The nucleic acid amplification reaction generates amplified nucleic acid and a plurality of protons.
[0213] The protons are then reacted with the optical property modifying reagent 1106. Reacting the reaction product or aspects thereof with the optical property modifying reagent may include chemically modifying the reaction product and / or the optical property modifying reagent, such as by binding one or more protons to the optical property modifying reagent. In some embodiments, this reaction of the protons with the optical property modifying reagent sufficiently modifies the optical property of the optical property modifying reagent to allow detection of the modified optical property indicative of the presence of a suspected analyte in the biological sample.
[0214] The system 805 causes 1107 the light emitting elements 410 to emit light. Specifically, the microprocessor 820 of the system 805 instructs the plurality of light emitting elements 410 to emit light in a repeating pattern at a repetition frequency. During the repeating pattern, each of the plurality of light emitting elements 410 emits light at a different point in time, such that only one of the plurality of fluid chambers 205 is illuminated at any time. Exposure to light can provide a change in conditions such that an optical property can be measured. In this way, during each repeating pattern, the optical property of the contents of each fluid chamber 205 can be continuously monitored by the photosensor 405.
[0215] Based on the optical properties detected in step 1107, the system 805 determines 1108 one or more characteristics of the sample contained in the fluid chamber 205. To determine the one or more characteristics of the sample, the photosensor 405 sends information about the detected optical properties to the microprocessor 820, and the microprocessor 820 analyzes this information. Specifically, the microprocessor 820 can perform an optical property analysis on the reaction mixture in one or more fluid chambers 205. Performing an optical property analysis can include determining whether a change in the optical property of one or more contents of the fluid chamber 205 has occurred.
[0216] Optical property analysis can be performed in real time in the whole amplification reaction described about step 1105, or can be performed after performing the amplification reaction.The detection of the modified optical property of the reaction mixture can be associated with the digital indication of the presence or absence of the amplification reaction product.In other words, the detection of the modified optical property of the reaction mixture can provide information about whether the amplification reaction product exists.In certain embodiments, the detection of the modified optical property of the reaction mixture indicates that the exponential phase or stable phase of the amplification reaction has been obtained.
[0217] In some embodiments, relative to the amplification reaction using a reaction mixture without a halogen-induced color-changing agent, the detection of the amplification reaction product is accelerated. In other embodiments, the optical property modification of the reaction mixture is detected in less than 60 minutes from the start time of the amplification reaction. The detection of the amplification reaction product is accelerated, because the salt color-changing agent (weak acid or weak base) in the reaction mixture absorbs the proton generated during the amplification reaction process, and the reorganization of the free proton plays a role in accelerating the detection of the amplification reaction. The reaction can be designed to require minimal amplification to generate a pH conversion sufficient to change the optical property of the salt color-changing agent. Conventional amplification techniques using fluorescent intercalating dyes, molecular beacons, hybridization probes, dye-based detection, UV-Vis or other detection methods require the amplification of a specific threshold amount before the amplification can be detected. However, the method of the present invention only requires a relatively small threshold amount of amplification before the optical property modification of the halogen-induced color-changing agent can be detected, and therefore, relative to conventional amplification methods, the detection of the amplification reaction product is accelerated.
[0218] The system 805 displays 1109 the determined characteristic using an electronic result display mechanism 835. Specifically, the microprocessor 820 transmits a signal including the determined characteristic to the electronic result display mechanism 835, where the result is simply and clearly provided to a user of the system 805. As noted above, the provided result may be in the form of a visual output on a display and / or in the form of an audio output.
[0219] It should be noted with respect to method 1100 that in various embodiments, system 805 includes one or more (e.g., three) assay controls: a sample adequacy control, a positive control (e.g., an internal positive control), and / or a negative control. The sample adequacy control detects, for example, abundant human nucleic acid markers, such as housekeeping genes, RNA, and / or human β-actin deoxyribonucleic acid (DNA), to ensure that sufficient swab samples are provided. The positive control amplifies synthetic oligonucleotides that may be co-packaged and / or co-lyophilized within fluid chamber 205. Such synthetic oligonucleotides may, for example, be included in an optical property modifying reagent solution and / or in an assay reagent. Such controls ensure that system 805 is operated under conditions that allow amplification of the genetic marker of interest. The negative control also amplifies the positive control, but without the co-lyophilized synthetic oligonucleotides. Such controls ensure that there are no contaminating self-amplified amplicons.
[0220] Example
[0221] Fig.121 is a line graph 1200 depicting absorbance signals detected by photosensor 405 over time for a plurality of reaction mixtures contained within a plurality of fluid chambers 205, according to an embodiment. A first subset of fluid chambers 205 includes experimental reaction mixtures 1305, and a second subset of fluid chambers 205 includes negative control mixtures 1310. Fig.12 In the example provided, the experimental reaction mixture 1305 includes a biological sample including a target nucleic acid, an optical property modification reagent solution, and an assay reagent. In addition, in this example, amplification of the target nucleic acid is expected to result in a decrease in absorbance. The negative control reaction mixture 1310 includes the same solution lacking the target nucleic acid.
[0222] like Fig.12 As shown, as the amplification reaction proceeds, the fluid chamber 205 including the experimental reaction mixture 1305 shows an increase in light detected by the photosensor 405 over time. In other words, as the amplification reaction proceeds, the fluid chamber 205 including the experimental reaction mixture 1305 shows a decrease in absorbance. This decrease in absorbance indicates an increase in the target nucleic acid present within the reaction mixture 1305.
[0223] On the other hand, as the amplification reaction proceeds, the fluid chamber 205 including the negative control reaction mixture 1310 does not show an increase in light detected by the photosensor 405 over time. In other words, as the amplification reaction proceeds, the fluid chamber 205 including the negative control reaction mixture 1310 does not show a decrease in absorbance. The lack of a decrease in absorbance indicates that the target nucleic acid is not present in the reaction mixture 1310.
[0224] Notice, Fig.12 1200 is arranged such that the fluid chambers 205 in which the experimental reaction mixtures 1305 and the negative control reaction mixtures 1310 are placed are alternating. In other words, each fluid chamber 205 containing an experimental reaction mixture 1305 is located between two fluid chambers 205 containing a negative control reaction mixture 1310, and each fluid chamber 205 containing a negative control reaction mixture 1310 is located between two fluid chambers 205 containing an experimental reaction mixture 1305. This layout and the resulting data expected and achieved in Figure 1200 both indicate that the system 805, and more specifically the device 105 on which the assay is performed, demonstrates limited crosstalk between adjacent fluid chambers 205. Specifically, Figure 1200 shows that optical signals transmitted through the first light pipe 210 and the second light pipe 140 are transmitted without interference from optical signals traveling through adjacent light pipes.
[0225] After reading this disclosure, those skilled in the art will understand additional alternative structures and functional designs through the principles disclosed herein. Therefore, although specific embodiments and applications have been shown and described, it should be understood that the disclosed embodiments are not limited to the precise configurations and components disclosed herein. Various modifications, changes and variations that are obvious to those skilled in the art may be made to the arrangement, operation and details of the methods and apparatus disclosed herein without departing from the spirit and scope defined by the appended claims.
[0226] As used herein, any reference to "one embodiment" or "an embodiment" means that a particular element, feature, structure, or characteristic described in conjunction with the embodiment is included in at least one embodiment. The phrase "in one embodiment" appearing in various places in this specification does not necessarily all refer to the same embodiment.
[0227] Some embodiments may be described using the expressions "coupled" and "connected" and their derivatives. For example, some embodiments may be described using the term "coupled" to indicate that two or more elements are in direct physical or electrical contact. However, the term "coupled" may also mean that two or more elements are not in direct contact with each other, but still cooperate or interact with each other. Unless otherwise expressly stated, the embodiments are not limited to this context.
[0228] As used herein, the terms "comprises," "comprising," "includes," "including," "has," "having," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a process, method, article, or apparatus that includes a list of elements is not necessarily limited to only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. In addition, unless expressly stated to the contrary, "or" refers to an inclusive "or" and not an exclusive "or." For example, any of the following satisfies condition A or B: A is true (or exists) and B is false (or does not exist), A is false (or does not exist) and B is true (or exists), and both A and B are true (or exist).
[0229] In addition, "a" or "an" is used to describe elements and components of the embodiments herein. This is done only for convenience and to give a general sense of the invention. This description should be understood to include one or at least one, and the singular also includes the plural, unless it is obvious that there is another meaning.
[0230] Some parts of this description describe embodiments of the present invention in terms of algorithms and symbolic representations of operations on information. These algorithmic descriptions and representations are typically used by technicians in the field of data processing to effectively convey the essence of their work to other technicians in the field. Although these operations are described functionally, computationally, or logically, they should be understood to be implemented by computer programs or equivalent circuits, microcodes, etc. In addition, it has also been demonstrated that it is sometimes convenient to refer to the arrangement of these operations as modules without loss of generality. The described operations and their associated modules can be embodied in software, firmware, hardware, or any combination thereof.
[0231] Any steps, operations or processes described herein may be performed or implemented using one or more hardware or software modules, either alone or in combination with other devices. In one embodiment, the software module is implemented using a computer program product, which includes a computer-readable non-transitory medium containing computer program code, which can be executed by a computer processor to perform any or all of the steps, operations or processes described.
[0232] Embodiments of the present invention may also be directed to products produced by the computing processes described herein. Such products may include information produced by the computing processes, wherein the information is stored on a non-transitory tangible computer-readable storage medium, and may include any embodiment of a computer program product or other data combination described herein.
Claims
1. A component for performing a bioassay, the component include: a first part, the first part comprising a first surface; as well as a second part, the second part comprising a second surface, wherein the first part and the second part are operatively coupled to form: Multiple independent continuous fluid paths; A common sample receiving inlet; a single sensing area comprising a single photosensor, wherein the single sensing area is located at or near a center of the second part, and wherein the single photosensor is concentrated within the single sensing area; a plurality of fluid channels extending from and in fluid communication with the common sample receiving inlet; as well as a plurality of fluid chambers, each fluid chamber comprising a fluid inlet in fluid communication with a terminal end of one of the plurality of fluid passages and an outlet vent at a terminal end of the fluid path, and a plurality of light emitting elements, each light emitting element being capable of individually illuminating one of the plurality of fluid chambers; The second part forms: (1) a plurality of first light pipes, each of which is capable of transmitting light between one of the plurality of fluid chambers and the single sensing area, and (2) a plurality of second light pipes, each of which is capable of transmitting light between one of the plurality of light emitting elements and one of the plurality of fluid chambers.
2. The assembly of claim 1 , wherein each of the plurality of first light pipes comprises at least one of one or more reflective surfaces and one or more refractive surfaces to direct light between a fluid chamber of the plurality of fluid chambers and the single sensing region; and Each of the plurality of second light pipes comprises at least one of one or more reflective surfaces and one or more refractive surfaces to guide light between a light emitting element of the plurality of light emitting elements and a fluid chamber of the plurality of fluid chambers.
3. The assembly of claim 1, further comprising a gasket located between the first part and the second part, the gasket being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path.
4. The assembly of claim 3, wherein the gasket comprises a thermoplastic elastomer (TPE) overmold.
5. The assembly of claim 3, wherein the gasket is pre-dried to a residual moisture between 0 and 0.4% w / w.
6. The assembly of claim 3, wherein the gasket is pre-dried to a residual moisture of at most 0.2% w / w.
7. The assembly of claim 1, wherein the first part further comprises a plurality of coupling handles, and the second part further comprises a plurality of coupling latches, and wherein each of the plurality of coupling handles is configured to operatively couple with one of the plurality of coupling latches.
8. The assembly of claim 3, wherein a volume of the gasket is compressed by 5% to 25% when the first part and the second part are operatively coupled.
9. The assembly of claim 1, wherein the outlet vent of each fluid chamber of the plurality of fluid chambers is sealed by a self-sealing vent material.
10. The assembly of claim 9, wherein the self-sealing vent material is pre-dried to a residual moisture of between 0 and 0.4% w / w.
11. The assembly of claim 9, wherein the self-sealing vent material is pre-dried to a residual moisture of at most 0.2% w / w.
12. The assembly of claim 1, further comprising a hydrophobic membrane between the first part and the second part, the hydrophobic membrane operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path.
13. The assembly of claim 12, wherein the hydrophobic membrane is welded to at least one of the first part and the second part using a plurality of energy directors.
14. The assembly of claim 12, wherein the outlet vent of each fluid chamber of the plurality of fluid chambers is sealed by the hydrophobic membrane.
15. The assembly of claim 12, wherein the hydrophobic membrane comprises polytetrafluoroethylene.
16. The assembly of claim 12, wherein the hydrophobic membrane is pre-dried to a residual moisture between 0 and 0.4% w / w.
17. The assembly of claim 12, wherein the hydrophobic membrane is pre-dried to a residual moisture of at most 0.2% w / w.
18. The assembly of claim 1, wherein at least one of the first part and the second part is injection molded.
19. The assembly of claim 1, wherein the second part comprises a material selected from the group consisting of polymethyl methacrylate, polystyrene, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, cyclic olefin copolymer, polyamide, and combinations thereof.
20. The assembly of claim 1, wherein the first part and the second part are pre-dried to a residual moisture between 0 and 0.4% w / w.
21. The assembly of claim 1, wherein the first part and the second part are pre-dried to a residual moisture of at most 0.2% w / w.
22. The assembly of claim 1, wherein the assembly has a shelf stability exceeding a threshold of 12 months.
23. The assembly of claim 1, wherein a volume of at least one fluid chamber of the plurality of fluid chambers is different than a volume of at least another fluid chamber of the plurality of fluid chambers.
24. The assembly of claim 1, wherein each fluid chamber of the plurality of fluid chambers has a volume between 1 uL and 1000 uL.
25. The assembly of claim 1, wherein at least one fluid chamber of the plurality of fluid chambers comprises a dry reagent.
26. The assembly of claim 25, wherein the dried reagents comprise assay reagents.
27. The assembly of claim 26, wherein the assay reagents comprise a nucleic acid amplification enzyme and a DNA primer.
28. The assembly of claim 1, further comprising: include: A circuit board including a microprocessor is operatively coupled to the fluid chamber.
29. The assembly of claim 1, wherein the plurality of light emitting elements comprise LEDs.
30. The assembly of claim 1, wherein the plurality of light emitting elements comprises lasers.
31. The assembly of claim 28, wherein the microprocessor is programmed to cause each of the plurality of light emitting elements to emit light in a repeating pattern having a repetition frequency in the range of 0.01 Hz to 100 Hz, wherein only one of the plurality of fluid chambers is illuminated at any time.
32. The assembly of claim 31 , wherein each fluid chamber of the plurality of fluid chambers is individually illuminated during each repetition of the pattern.
33. The assembly of claim 1, wherein the photosensor comprises one of a CMOS chip, a photodiode, a phototransistor, a photocell, and a photomultiplier tube.
34. The assembly of claim 1, wherein the photosensor is configured to detect a color change.
35. The assembly of claim 1, wherein the photosensor is configured to detect changes in absorbance.
36. The assembly of claim 28, wherein the circuit board further comprises a heating element, the heating element comprising a ring shape, the heating element configured to heat the plurality of fluid chambers.
37. The assembly of claim 36, further comprising a thermally conductive pad comprising an annular shape, the thermally conductive pad configured to transfer heat from the heating element to the plurality of fluid chambers.
38. The assembly of claim 36, wherein the circuit board further comprises a temperature sensor.
39. The assembly of claim 28, wherein the circuit board further comprises an electronic results display mechanism.
40. The assembly of claim 28, wherein the microprocessor is programmed to analyze signals received from the photosensor.
41. The assembly of claim 36, wherein the microprocessor is programmed to generate a signal for transmission to the heating element.
42. The assembly of claim 38, wherein the microprocessor is programmed to analyze signals received from the temperature sensor.
43. The assembly of claim 39, wherein the microprocessor is programmed to generate a signal for transmission to the electronic result display mechanism.
44. The assembly of claim 1, wherein the bioassay is a diagnostic test.
45. The assembly of claim 1, wherein the plurality of fluid channels extend radially from the common sample receiving inlet.
46. The assembly of claim 1, wherein the plurality of fluid chambers are radially arranged around the single sensing region.
47. The assembly of claim 1, wherein the plurality of first light guides are radially arranged around the single sensing region.
48. The assembly of claim 1, wherein the first face is radially symmetric.
49. The assembly of claim 1, wherein the second face is radially symmetric.
50. A system for performing a bioassay, the system include: A component, the component comprising: a first part, the first part comprising a first surface; a second part, the second part comprising a second surface, wherein the first part and the second part are operatively coupled to form: Multiple independent continuous fluid paths; A common sample receiving inlet; a single sensing area, wherein the single sensing area is located at or near a center of the second part; a plurality of fluid channels extending from and in fluid communication with the common sample receiving inlet; and a plurality of fluid chambers, each fluid chamber comprising a fluid inlet in fluid communication with an end of one of the plurality of fluid passages and an outlet vent at an end of the fluid path, the outlet vent being sealed by a material; and a circuit board operatively coupled to the fluid chamber, the circuit board comprising: microprocessor; a plurality of light emitting elements, each light emitting element being capable of individually illuminating one of the plurality of fluid chambers; a photosensor optically coupled to the single sensing region, and wherein the single photosensor is concentrated within the single sensing region; a heating element, the heating element comprising an annular shape, the heating element being configured to heat the plurality of fluid chambers; temperature sensor; and Electronic results display agency; wherein the second part forms: (1) a plurality of first light pipes, each of which is capable of transmitting light between one of the plurality of fluid chambers and the single sensing region, and (2) a plurality of second light pipes, each of which is capable of transmitting light between one of the plurality of light emitting elements and one of the plurality of fluid chambers; and wherein the microprocessor is programmed to cause each of the plurality of light emitting elements to emit light in a repeating pattern at a repetition frequency, wherein only one of the plurality of fluid chambers is illuminated at any time, and wherein the microprocessor is further programmed to analyze a signal received from the photosensor to generate a signal to be transmitted to the heating element, analyze a signal received from the temperature sensor, and generate a signal to be transmitted to the electronic result display mechanism.
51. The system of claim 50, wherein each of the plurality of first light pipes comprises at least one of one or more reflective surfaces and one or more refractive surfaces to direct light between a fluid chamber of the plurality of fluid chambers and the single sensing region; and Each of the plurality of second light pipes comprises at least one of one or more reflective surfaces and one or more refractive surfaces to guide light between a light emitting element of the plurality of light emitting elements and a fluid chamber of the plurality of fluid chambers.
52. The system of claim 50, further comprising a gasket positioned between the first part and the second part, the gasket being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path.
53. The system of claim 52, wherein the gasket comprises a thermoplastic elastomer (TPE) overmold.
54. The system of claim 52, wherein the pad is pre-dried to a residual moisture between 0 and 0.4% w / w.
55. The system of claim 52, wherein the pad is pre-dried to a residual moisture of at most 0.2% w / w.
56. The system of claim 50, wherein the first part further comprises a plurality of coupling handles, and the second part further comprises a plurality of coupling latches, and wherein each of the plurality of coupling handles is configured to be operatively coupled to one of the plurality of coupling latches.
57. The system of claim 52, wherein a volume of the gasket is compressed by 5% to 25% when the first part and the second part are operatively coupled.
58. The system of claim 50, wherein the material sealing the outlet vent of each fluid chamber of the plurality of fluid chambers is a self-sealing vent material.
59. The system of claim 58, wherein the self-sealing vent material is pre-dried to a residual moisture between 0 and 0.4% w / w.
60. The system of claim 58, wherein the self-sealing vent material is pre-dried to a residual moisture of at most 0.2% w / w.
61. The system of claim 50, further comprising a hydrophobic membrane between the first part and the second part, the hydrophobic membrane operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path.
62. The system of claim 61, wherein the hydrophobic membrane is welded to at least one of the first part and the second part using a plurality of energy directors.
63. The system of claim 61, wherein the outlet vent of each fluid chamber in the plurality of fluid chambers is sealed by the hydrophobic membrane.
64. The system of claim 61, wherein the hydrophobic membrane comprises polytetrafluoroethylene.
65. The system of claim 61 , wherein the hydrophobic membrane is pre-dried to a residual moisture between 0 and 0.4% w / w.
66. The system of claim 61 , wherein the hydrophobic membrane is pre-dried to a residual moisture of at most 0.2% w / w.
67. The system of claim 50, wherein at least one of the first part and the second part is injection molded.
68. The system of claim 50, wherein the second part comprises a material selected from the group consisting of polymethyl methacrylate, polystyrene, polycarbonate, polypropylene, polyethylene, polyethylene terephthalate, cyclic olefin copolymer, polyamide, and combinations thereof.
69. The system of claim 50, wherein the first part and the second part are pre-dried to a residual moisture between 0 and 0.4% w / w.
70. The system of claim 50, wherein the first part and the second part are pre-dried to a residual moisture of at most 0.2% w / w.
71. The system of claim 50, wherein the components have a shelf stability exceeding a threshold of 12 months.
72. The system of claim 50, wherein a volume of at least one fluid chamber of the plurality of fluid chambers is different than a volume of at least another fluid chamber of the plurality of fluid chambers.
73. The system of claim 50, wherein each of the plurality of fluid chambers has a volume between 1 uL and 1000 uL.
74. The system of claim 50, wherein at least one fluid chamber of the plurality of fluid chambers comprises a dry reagent.
75. The system of claim 74, wherein the dried reagents comprise assay reagents.
76. The system of claim 75, wherein the assay reagents comprise a nucleic acid amplification enzyme and a DNA primer.
77. The system of claim 50, wherein the repetition frequency is in the range of 0.01 Hz to 100 Hz.
78. The system of claim 50, wherein each fluid chamber of the plurality of fluid chambers is individually illuminated during each repetition of the pattern.
79. The system of claim 50, wherein the photosensor comprises one of a CMOS chip, a photodiode, a phototransistor, a photocell, and a photomultiplier tube.
80. The system of claim 50, wherein the photosensor is configured to detect a color change.
81. The system of claim 50, wherein the photosensor is configured to detect changes in absorbance.
82. The system of claim 50, further comprising a thermally conductive pad comprising an annular shape, the thermally conductive pad configured to transfer heat from the heating element to the plurality of fluid chambers.
83. The system of claim 50, wherein the bioassay is a diagnostic test.
84. The system of claim 50, wherein the plurality of light emitting elements comprises LEDs.
85. The system of claim 50, wherein the plurality of light emitting elements comprises lasers.
86. The system of claim 50, wherein the plurality of fluid channels extend radially from the common sample receiving inlet.
87. The system of claim 50, wherein the plurality of fluid chambers are radially arranged around the single sensing region.
88. The system of claim 50, wherein the plurality of first light guides are radially arranged around the single sensing region.
89. The system of claim 50, wherein the first face is radially symmetric.
90. The system of claim 50, wherein the second face is radially symmetric.
91. A method for determining one or more characteristics of a nucleic acid amplification sample based on modified optical properties of the sample, the method include: Receiving the system according to claim 50; providing a biological sample including nucleic acid; combining the biological sample with an optical property modifying reagent solution to produce a sample solution; inserting the sample solution into the common sample receiving inlet; transferring at least a portion of the sample solution from the common sample receiving inlet into the plurality of fluid channels, and from distal ends of the plurality of fluid channels into the fluid inlets of the plurality of fluid chambers extending from and in fluid communication with the common sample receiving inlet, wherein the fluid chambers include assay reagents, thereby generating a nucleic acid reaction mixture; heating the reaction mixture with the heating element, wherein the heating promotes a nucleic acid amplification reaction between nucleic acids present in the biological sample and the assay reagents, the reaction generating amplified nucleic acids and a plurality of protons; reacting the protons with the optical property modifying agent, wherein the reaction is capable of modifying an optical property of the optical property modifying agent to allow detection of the modified optical property indicative of the presence of a suspected analyte in the biological sample; Using the microprocessor, causing each of the plurality of light emitting elements to emit light in a repeating pattern at a repetition frequency; using the photosensor, determining one or more characteristics of the sample based on the modified optical properties; as well as The determined characteristics are displayed using the electronic results display mechanism of the system.
92. The method of claim 91, wherein each light emitting element individually illuminates one fluid chamber of the plurality of fluid chambers.
93. The method of claim 91, wherein each fluid chamber of the plurality of fluid chambers is individually illuminated during each repetition of the repeating pattern.
94. The method of claim 91, wherein the light emitted by the plurality of light emitting elements is transmitted to the plurality of fluid chambers through the plurality of second light pipes.
95. The method of claim 94, wherein the light emitted by the plurality of light emitting elements is transmitted to the plurality of fluid chambers through the plurality of second light pipes using at least one of one or more reflective surfaces and one or more refractive surfaces located within the plurality of second light pipes.
96. The method of claim 91, wherein the light emitted by each of the plurality of light emitting elements is transmitted to the photosensor through the plurality of first light guides of the second part.
97. The method of claim 91, wherein causing each of the plurality of light emitting elements to emit light in the repeating pattern further comprises: include: Each of the plurality of light emitting elements is caused to emit light at different and distinct times such that only one of the plurality of fluid chambers is illuminated at any time.
98. The method of claim 91, wherein the heating element is used to heat the reaction mixture. include: The signal generated by the microprocessor is transmitted to the heating element.
99. The method of claim 91, wherein determining one or more characteristics of the sample using the photosensor further comprises: include: The microprocessor analyzes the signals received from the photosensor.
100. The method of claim 91, further comprising: include: A signal is received from a temperature sensor of the system, and the signal received from the temperature sensor is analyzed using the microprocessor.
101. The method of claim 91, wherein the electronic result display mechanism is used to display the determined characteristic. include: The signals generated by the microprocessor are transmitted to the electronic result display mechanism.
102. The method of claim 91, further comprising: include: The first part and the second part are pre-dried to a residual moisture between 0 and 0.4% w / w.
103. The method of claim 91, further comprising: include: The first part and the second part are pre-dried to a residual moisture of at most 0.2% w / w.
104. The method of claim 91, wherein the material sealing the outlet vent of each fluid chamber in the plurality of fluid chambers is a self-sealing vent material, and wherein the method further include: The self-sealing vent material is pre-dried to a residual moisture between 0 and 0.4% w / w.
105. The method of claim 91, wherein the material sealing the outlet vent of each fluid chamber in the plurality of fluid chambers is a self-sealing vent material, and wherein the method further include: The self-sealing vent material is pre-dried to a maximum of 0.2% w / w residual moisture.
106. The method of claim 91, wherein the system further comprises a gasket located between the first part and the second part, the gasket being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path, and wherein the method further comprises: include: The pads were pre-dried to a residual moisture between 0 and 0.4% w / w.
107. The method of claim 91, wherein the system further comprises a gasket located between the first part and the second part, the gasket being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path, and wherein the method further comprises: include: The pads were pre-dried to a maximum of 0.2% w / w residual moisture.
108. The method of claim 91, wherein the system further comprises a hydrophobic membrane between the first part and the second part, the hydrophobic membrane being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path, and wherein the method further comprises: include: The hydrophobic membrane was pre-dried to a residual moisture between 0 and 0.4% w / w.
109. The method of claim 91, wherein the system further comprises a hydrophobic membrane between the first part and the second part, the hydrophobic membrane being operatively coupled to the first part and the second part to form a fluid seal in the continuous fluid path, and wherein the method further comprises: include: The hydrophobic membrane was pre-dried to a maximum of 0.2% w / w residual moisture.
110. The method of claim 91, wherein the repetition frequency is in the range of 0.01 Hz to 100 Hz.
111. The method of claim 91, wherein using the photosensor to determine one or more characteristics of the sample further comprises: include: The photosensor is used to detect the color change of the sample.
112. The method of claim 91, wherein using the photoelectric sensor to determine one or more characteristics of the sample further comprises: include: The photoelectric sensor is used to detect the absorbance change of the sample.
113. The method of claim 91, wherein the optical property modifying reagent solution comprises a liquid buffer.
114. The method of claim 91, wherein the assay reagents comprise a nucleic acid amplification enzyme and a DNA primer.
115. The method of claim 91, wherein the assay reagent is dried.
